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SUMMARY
I t  has been suggested that a gastric ulcer results when the 
a b ility  of the stomach to defend its e lf  against the aggressive 
forces of the gastric contents breaks down. The studies in this  
dissertation are concerned with the effects of agents on the 
synthesis of mucosal glycoproteins, the principle components of 
gastric mucus which constitutes the f i r s t  line of defence of the 
gastric mucosa.
Studies on the synthesis of mucosal glycoproteins, employing the 
in v itro  incorporation of radiolabelled precursors, showed that human 
gastric ulcer was associated with a derangement of mucus synthesis 
characterised by decreased incorporation rates of N-acetylglucosamine.
In contrast sulphate uptake appeared to be increased in disease states.
Whereas predosing animals with mucosal damaging agents, such as 
ethanol, or a period of starvation,produced reductions, carbenoxolone 
and the E type prostaglandins, which have been shown to be beneficial 
in the treatment of ulceration, caused marked increases in the rate of 
incorporation of N-acetylglucosamine.
Further studies with carbenoxolone indicated that the e ffec t of 
the drug is on the degree of glycosylation of the glycoprotein rather 
than on the amount produced. I t  is suggested that carbenoxolone results 
in the production of a modified glycoprotein carbohydrate side chain, 
richer in N-acetylglucosamine, N-acetylgalactosamine, N-acetylneuraminic 
acid and fucose and depleted with respect to galactose. The drug also 
resulted in increased sulphation of mucosal glycoprotein.
Carbenoxolone has also been investigated in relation to its  effect
on the release of lysosomal enzymes which have been shown to be elevated
in drug induced gastric mucosal lesions. The results show that the
drug is extremely membrane active causing lysis of lysosomal membranes
at high concentrations (above 1(T^M) and stab ilization  at lower 
-5concentrations (10 M).
The significance of these findings with relation to ulceration and 
the beneficial action of anti-ulcerogenic drugs is discussed.
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CHAPTER ONE 
GENERAL INTRODUCTION
1.1 The Stomach - structure and function
1.2 Ulceration
1.3 Carbenoxlone Sodium
1.4 Aim of project
1.1 THE STOMACH - STRUCTURE AND FUNCTION
The stomach develops as an unequal d ilatation of the foregut.
The ventral and dorsal surfaces may be vaulted or flattened and may 
touch when the organ is empty. I t  has two borders; the concave 
lesser curve and the convex greater curve. These jo in  at the cardia 
where the oesophagus enters (Fig, 1 .1 ). On the right the oesophagus 
continues smoothly into the lesser curvature but on the le f t  there 
is a defin ite  indentation known as the cardiac incisure.
The major portion of the stomach, known as the corpus or body, 
blends imperceptably with the pyloric portion, except along the lesser 
curvature, where the angular incisure marks the boundary between the 
corpus and the pyloric region. The la tte r  is divided into the pyloric 
antrum or vestible which narrows into the pyloric canal, terminating 
at the pylorus.
The mammalian gastric mucosa may be classified as glandular or 
non-glandular. The former is present in a ll stomachs and is responsible 
for the secretion of gastric ju ice. Non-glandular mucosa is found in 
certain species only (e .g . the fundic region of the ra t, mouse and 
guinea pig stomachs).
The mucous membrane of the stomach, composed of a single layer of 
ep ithelia l ce lls , the tunica propria and the submucosa, commences at 
the cardia along an irregular zig-zag line (the z lin e ). Here the 
mucosa consists of marked re lie fs  of rugae, which fla tte n  considerably 
as the stomach is distended. In the region of the lesser curve where 
the mucosa is strongly fixed to the muscular layer, the folds take a 
longitudinal course, forming the "Magenstrasse". The rugae are smaller 
in the fundus and become larger as they approach the antrum where they 
tend to run diagonally across the stomach towards the greater curvature.
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Figure 1.1 THE HUMAN STOMACH
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Besides these broad folds the mucosal surface is further 
characterized by numerous shallow invaginations. These areae 
gastricae contain delicate ledges and depressions, the la tte r  
known as the gastric pits or foveolae gastricae. In the depths of 
these pits the glands of the stomach open.
At the gastro-oesophageal junction the gastric epithelium, 
consisting of a single layer of columnar ce lls , is sharply 
demarcated from the s tra tifie d  and thicker oesophageal mucosa.
The ep ithelia l cells are of the mucoid type, containing mucinogen 
granules in th e ir outer portions and a single ovoid nucleus at the ir  
base.
The glands of the stomach are tubular and can be sub-divided 
into three types (Fig. 1.2) -
(1) The cardiac glands. These are confined to a narrow zone,
0.5 to 4 cm in width, around the cardiac o r if ic e . They are coiled
and lined by mucus producing ce lls .
(2) The gastric or fundic glands. These are located in the 
fundus and cover the greater part of the body of the stomach. They 
are reasonably straight, simple branched tubules, with a narrow lumen 
reaching down almost to the muscularis mucosa. Three types o f cell 
are found:-
(a) Mucus secreting c e lls . The neck of the gland is lined by
mucus secreting ce lls . These d iffe r  from the cells of the surface
epithelium in that their mucinogen granules have s lig h tly  d ifferen t 
staining properties and the ir nuclei tend to be flattened or concave 
rather than oval.
(b) Chief c e lls . The chief or zymogenic cells line the lower ha lf 
of the glandular tubules. They have spherical nuclei, contain dense
Figure 1.2 Glands and Cell Types in the Gastric Mucosa
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ligh t-re fracting  granules and golgi apparatus, the size and form 
of which vary with the state of secretory a c tiv ity . These cells  
are responsible for pepsinogen secretion.
(c) Parietal c e lls . These cells are longer than the chief and mucus 
secreting, cells and are usually crowded away from the lumen to which 
they connect by a series of extracellu lar cap illa ries , stemming 
from in trace llu la r canaliculi. The parie ta l, or oxyntic cells
are responsible for the production of gastric hydrochloric acid,
and (3) The pyloric glands. These are located in the pyloric region
but also spread into a transitional zone, in which both gastric and
pyloric glands are found and which extends diagonally and d is ta lly  from 
the lesser to the greater curvature. The tubes of the pyloric glands 
are shorter, more tortuous, less densely packed and less branched than 
the fundic glands. These glands are lined by a single type of c e il,  
which is mucus secreting and resembles closely the mucous neck cells  
of the fundic glands.
Three other cell types are present in the human antrum; i )  argentaffine 
ce lls , which contain 5-hydroxy-tryptamine and are found in the deeper glands; 
i i )  apud ce lls , which are morphologically related to the argentaffine 
cells and may contain histamine, and ( i i i )  cells provisionally termed 'S' 
ce lls , which are found at the base of the gastric p its . 'S' cells are 
thought, mainly on the basis of the vesicles and fibres they contain, to 
be either secretory ce lls , monitoring the acidity of the gastric mucosa, 
or cells producing secretin.
The secretory products of a ll these various cells constitute gastric  
ju ice . The cell types and th e ir secretory products are summarized in 
Table 1.1.
Table 1.1 Cell types found in the gastric mucosa 
and th e ir secretory products
Cell type 
Surface mucous 
Mucous
Oxyntic (parie ta l) 
Chief (zymogen) 
Argentaffine 
Gastrin
Pyloric gland (mucous)
Product(s)
Mucus
Groups I and I I  pepsinogens, mucus 
Acid, in trins ic  factor 
Groups I and I I  pepsinogens 
Serotonin, histamine 
Gastrin
Group I I  pepsinogen, mucus
Gastric secretion is under both nervous and hormonal control.
The neural control is via the vagus nerves. Vagal ac tiv ity  or 
distension of the stomach wall by food stimulates exocrine secretion 
of acid and pepsin, endocrine secretion of gastrin and sensitizes 
parietal cells to the action of gastrin.
When stimulation fades and inhibition occurs, gastric secretion 
subsides. Satiety stops cortical stimulation of the vagi and the 
low pH of the gastric contents prevents further release of gastrin. 
Hormonal inhibitors of secretion are secretin and cholecystokinin.
The duodenal mucosa releases these hormones when food and gastric  
ju ice pass from the stomach.
There is some evidence to suggest that a second messenger 
hypothesis for mediation of ce llu la r responses to hormones and other 
agents may apply to oxyntic ce lls . I t  has been suggested that cyclic  
AMP f u l f i l ls  this role (Harris et jf [ ,  1965; 1969) via its  action on 
carbonic anhydrase (Bersimbaev et 1971; Salganik et al_, 1972).
This enzyme plays an important role in the secretion of the HC1, being 
involved in the formation of hydrogen ions and the ir transport through 
the cell w a ll.
Cyclic AMP mediates the action of a number of hormones by 
activation of protein kinases in target ce lls . The protein kinases 
in turn phosphorylate defin ite  enzymes or other proteins, resulting in 
the physiological effect of the hormone. I t  is possible that changes 
in carbonic anhydrase a c tiv ity  produced by cyclic AMP may also arise as 
a result of such an enzymic protein phosphorylation.
Bersimbaev and his co-workers (1971) have proposed a scheme to explain 
the effects of various secretagogues on cyclic AMP and gastric acid 
production in the ra t. In this scheme gastrin and histamine stimulate 
the production of cyclic AMP, the second messenger, which controls the 
production of HC1 by its  effect on carbonic anhydrase. The hypothesis 
is supported by their finding that theophylline, an inhibitor of phos­
phodiesterase augmented the effect of the secretagogues on acid production 
(see Fig. 1 .3 ).
This second messenger role for cyclic AMP has received support from 
a large number of authors, with regard to acid secretion by the rat 
( Dornschke et a l , 1973; Puurenen and Karppanen, 1975), guinea pig (Karppanen 
et a l, 1974), rabbit (Fromm et a l , 1975) and frog gastric mucosae (Harris 
et a l,  1965; 1969). Conflicting findings, however, have been reported for 
canine (Levine and Wilson, 1971; Mao et al_, 1973) and human gastric mucosae 
(Domschke et aj_, 1974; 1975). The evidence for and against the role of 
cyclic AMP in the control of acid secretion has been reviewed recently 
(Kimberg, 1974).
Recently, a large volume of work has been devoted to elucidating the 
role of prostaglandins in the stomach. Of the prostaglandins which can 
be isolated from the gastric mucosa of the ra t (PGE-J, PGE ,^ 'PGF.-j ■ and 
PGF^, Shaw and Ramwell, 1968), PGE^  and PGE£ have been shown to in h ib it 
secretion in rats (Robert, 1968; Shaw and Ramwell, 1968; Main and W hittle, 
1973), dogs (Robert et al_, 1967; Nezamis et al ,^ 1971) and humans (Claussen 
et al_, 1970).
Another naturally occurring series of prostaglandins, PGA-j and PGA ,^ 
which have also been studied with regard to gastric secretion, causes 
inhibition in rats (Main and W hittle, 1973), dogs (Robert et aj[, 1967) 
and humans (Wilson et a l,  1971).
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The available evidence suggests that the prostaglandins possess a 
broad spectrum of anti-secretory ac tiv ity  rather than a specific  
antagonist action. Whereas PGE-j e ffective ly inhibited gastric secretion 
induced by a number of secretagogues including histamines and food, in 
the dog, PGA^  was effective against food-induced but not histamine- 
induced secretion (Robert et a_U 1967). Furthermore, in human studies 
PGA-j has been shown to inh ib it histamine-induced secretions (Wilson 
et aj[, 1971).
The mechanism of the anti-secretory action of prostaglandins is not 
known. They have potent effects on the gastric mucosal blood flow in 
dogs (Robert et a l,  1967) and the rat (Main and W hittle, 1972, 1973a, 
1973b) but this effect may be to increase or decrease the blood flow, 
depending on the dose of prostaglandin and is believed by these authors 
to be secondary to the inhibition of acid secretion.
Evidence has accumulated suggesting that the prostaglandins act 
through cyclic AMP. Thus the infusion of prostaglandin into dogs with 
Heidenhain pouches significantly  decreased the amount of cyclic AMP 
secreted into the gastric juice as well as the amount of acid secreted 
(Bieck et a l,  1973). Other experimental studies, however, have fa iled  
to demonstrate the importance of cyclic AMP in the control of canine 
gastric secretion (Mao et al_, 1972).
In the rat cyclic AMP induced secretion is p a rtia lly  inhibited by 
PGEg (W hittle, 1972) and dibuteryl cyclic AMP stimulated secretion can 
be antagonised by PGE^  (Jawaharlal and B erti, 1972). In contrast PGE-j 
inhibited gastrin and histamine but not cyclic AMP induced-secretions 
in the frog stomach (Way and Durbin, 1969).
Thus the interaction of prostaglandins with cyclic AMP levels may 
be d ifferen t in d ifferent species and the evidence in favour of such an 
interaction playing an important role in the control of acid secretion 
remains unconvincing.
Gastric Mucus
Gastric mucus is secreted by the cells of the surface epithelium 
and those lining the crypts of the mucosa and pyloric glands. I t  is 
highly alkaline and viscous, covering the surface of the mucosa with 
a tenacious layer about 1 mm thick.
I t  is firm ly established that glycoproteins are the principle
components of gastric mucus (Spiro, 1970). Studies on mucosubstances
from the stomach of the pig, which physiologically is closely related
to that of man (Montagna, 1959) indicate that gastric mucus contains
6 5two glycoproteins of molecular weight 2.3 x 10 and 1.1 x 10 (Allen 
and Snary, 1972). These mucoproteins are closely related, being 
identical in A and H blood group a c tiv itie s , chemical analysis and in 
many physical properties (Snary and Allen, 1971). For these reasons the 
high molecular weight glycoprotein is thought to be a polymer of the 
low molecular weight molecule.
These glycoproteins are characterised by a high content of serine, 
threonine and proline, which together account for 40% of the to ta l amino 
acids present (Starky et aj_, 1972). Serine and threonine are thought to 
be the amino acids involved in the peptide-carbohydrate link (Marshall, 
1972; Slomiany and Meyer, 1972). The sum of these two amino acids 
approximately equals the number of N-acetyl-D-galactosamine residues, 
a relationship which is thought to indicate the involvement of this  
residue in the linking of the side chains (Schrager, 1969). The other
carbohydrate moieties involved in the side chains of gastric mucosal 
glycoproteins are galactose, fucose, glucosamine, galactosamine 
and s ia lic  acid (Schrager and Oates, 1970).
The protection afforded by the mucus layer is partly mechanical, 
preventing access of acid and pepsin to the ep ithelia l cells (Johnson,
1957) and partly chemical because i t  can neutralise acid to some extent; 
the former function, however, is more important than the la t te r  (Grossman,
1958).
That the carbohydrate side chain plays an important role in the 
protection afforded by mucus is evidenced by the work of Gottschalk 
(1960) who found that the viscosity of mucus, an important factor in 
its  adhesion to the mucosa, is dependent on the s ia lic  acid content of 
the glycoprotein. The role of s ia lic  acid in maintaining the in tegrity  
of the mucus coat was further supported by Domschke et £  (1972) who 
found that N-acetylneuraminic acid levels were sign ificantly  decreased 
in the mucus of gastric ulcer patients.
Studies with ulcerogenic drugs have also demonstrated the protective 
function of mucus and the importance of the carbohydrate side chains in 
maintaining this function. Aspirin (Menguy et al ,^ 1965), phenylbutazone 
(Menguy and Desbaillets, 1967a) and indomethacin (Menguy and Desbaillets, 
1967b), which lead to gastric lesions, cause a decrease in the synthesis 
of mucus and also a decrease in the concentration of protein bound 
carbohydrates, particularly s ia lic  acid and hexosamines. Moreover, the
same authors (Menguy and Desbaillets, 1968) found that mucus which was
!
deficient in carbohydrate was more susceptible to proteolytic digestion.
The structure, function and biosynthesis of glycoproteins and the 
effects of agents upon these aspects of gastric mucus w ill be discussed 
in fu lle r  detail in Chapter 2.
1.2 ULCERATION
Peptic Ulcer. Peptic ulcer can be defined as a sharply circumscribed 
loss of tissue, involving the mucosa, submucosa and muscular layer, 
occurring in areas of the digestive trac t exposed to acid and pepsin 
containing gastric ju ice. Thus the disease may occur in the lower 
part of the oesophagus, the small intestine and the stomach. In the 
la t te r  region the lesion constitutes a gastric ulcer.
Pathophysiology of the gastric ulcer
Most gastric ulcers occur along the lesser curvature of the stomach 
and are associated with hyposecretion of acid. Johnson (1965) found 
that this group comprised 57% of his large series of 5,000 cases.
Acute and chronic ulcers d iffe r  chiefly in the amount of granulation 
tissue and fibroplasia. Acute erosions extend only to the muscularis 
mucosa and superficial ulcers to the upper portion of the submucosa.
They are usually m ultiple, oval or round and vary in diameter from several 
millimeters to one or two centimeters.
Chronic gastric ulcer is usually single, but may be m ultip le. The 
crater is oval or e l l ip t ic a l,  with overhanging edges. Crater diameter 
may vary from several millimeters to several centimeters and the depth 
from 10 to 20 mm or more. The adjacent mucosa may be normal, inflamed 
or atrophic. Microscopically, chronic gastric ulcer is a "U" shaped 
defect, extending through the mucosa and submucosa to a varying depth in 
the muscularis propria. Occasionally i t  may penetrate the serosal layer, 
invading the pancreas or liv e r .
The ulcer base typ ically  comprises four zones:- on the surface a 
greyish exudate of leukocytes, overlying a zone of fib rino id  necrosis,
superimposed on a layer of granulation tissue which blends with the 
underlying c icatrical zone. The muscular layers are interrupted 
completely by the ulceration and fibrous tissue. A ctiv ity  and healing 
co-exist in the same lesion.
In acute ulcers the blood vessels are normal but in the subacute 
and chronic lesions the vascular changes may include p a rtia lly  organised 
thrombi, a r te r it is , p e ria rte r itis  and subintimal pro liferation of 
connective tissue. There may also be inflammation and degeneration 
of nerve fibres and disappearance of ganglion ce lls .
Distribution
Knowledge of the gastric ulcer apparently dates from antiqu ity , but
the reports were vague until the report of Mathew B aiH ie (1793).
Cruveilhier in 1829 described the lesion in detail and Brinten published 
a comprehensive account in 1857, based on more than 7,000 autopsies.
Peptic ulceration is a disorder of man. Erosions and superficial 
lesions occur spontaneously in many species but chronic ulcers are rare.
The disease is a common one, the incidence being possibly as high as 10%
(Doll e t a[[, 1951) of the population. Before 1900 the frequency of 
gastric ulcer exceeded that of duodenal ulcer and females were affected  
more often than males. These trends have now been reversed - ra tio  o f 
duodenal ulcer to gastric ulcer 10:1 (Watkinson, 1960) -  except in 
Japan where gastric ulcer is more common than duodenal ulcer (Rhodes, 
1972) and in Finland where the incidence is approximately equal. Gastric
i
. i
ulceration is also very common among Indians of the Peruvian Andes, 
developing at an early age and often being complicated by haemorrhage.
The high a ltitu de , the coarse nu tritionally  inadequate d ie t, chewing of 
cocoa beans, hot alcoholic beverages and hazardous work have a ll been 
implicated as causative factors.
Peptic ulcers occur at a ll ages but symptoms usually develop 
between the ages of 20 and 40. The highest incidence for the disease 
occurs between the ages of 45 and 55. Until puberty, the sex 
distribution of peptic ulcer is the same. After puberty the 
incidence of the disease increases in both sexes, but more in males 
than females. Among adults males predominate in a ratio  o f 4:1 for 
gastric ulcer. After a r t i f ic ia l  or spontaneous menopause the incidence 
of ulceration in women rises. Active ulceration is a rare phenomenon 
during pregnancy but may recurr in the las t trimester or early puerperium. 
These observations in women indicate a sex linked protection against 
ulceration.
The striking incidence of peptic ulcer in some fam ilies, the 
frequency among liv ing siblings of ulcer patients and the occasional 
ulcers in homozygous twins indicate genetic influences. There is an 
interesting relationship between the distribution of blood groups in 
patients with peptic ulcer. Individuals who belong to blood group 0 
and whose genes determine that they do not secrete A, B or H blood group 
substances, have a 2.5 times greater risk of developing ulcers than 
persons of blood groups A or AB who are secretors of these substances.
The Gastric Mucosal Barrier 1
I t  has been stated that peptic ulceration is a common lesion. One 
of the most interesting facets of the disease is why i t  does not occur 
more frequently than i t  does, in view of the digestive capabilities of 
the gastric contents. Between the stomach contents and the plasma there 
is a ; H+gradient of over 1 m illion to 1. The remarkable a b ility  of the 
stomach to maintain this gradient is due to the gastric mucosal b arrie r, 
a concept at f i r s t  proposed by Teorell (1933). This barrier is dependent 
on two factors, the superficial layer of mucus which covers the epithelium
Table 1.2 The Aggressive and Defensive Factors Associated 
with Gastric Ulceration
Aggressive Factors
Increased acid production
Increased pepsinogen synthesis
Decreased mucus synthesis
Refluxed duodenal contents 
ora lly  ingested chemical 
ir r ita n ts  (e .g . aspirin)
Defensive Factors
Decreased acid synthesis
Decreased pepsin synthesis
Increased mucus synthesis
Increased s ta b ility  of 
mucosal cells
(From Bralow, 1969)
(see section 1.1) and the remarkable regenerative a b ility  of the 
gastric mucosal epithelium (Lipkin, 1971).
The ce llu la r defence mechanism depends on the very rapid turnover 
of cells in the gastric mucosa. Lipkin and Bell (1968) have demonstrated 
the dynamic and rapid life -c y c le  of the mucus producing gastric ep ithelia l 
cells in man and other species. New cells are produced in the gastric 
pits and rapidly move to the surface to replace those extruded into the 
lumen. As the new cells migrate they undergo d iffe ren tia tion , which 
enables them to produce mucus. At the same time there is a decrease in 
DNA synthesis (Lipkin, 1971). These cells have a short l i f e  span, being 
extruded into the lumen within 3 days, but they are constantly being 
replaced by new migrating ce lls .
Mechanisms of Gastric Ulcer Formation
An ulcer develops in a stomach, when at a circumscribed s ite  the 
resistance of the mucosa to acid and pepsin breaks down. Thus a pre­
requisite fo r the development of an ulcer is the digestive ju ice of the 
stomach and "no acid -  no ulcer" (Schwartz, 1910) is the only unchallenged 
basic principle of ulcer formation.
The disease appears to be dependent on the interplay of a number of 
factors, n u tritio n a l, vascular, nervous, humoral and chemical and results 
from an in a b ility  of the stomach to cope with the many aggressive factors 
with which i t  comes into contact during normal function. Whether the 
ulcer results from an increase in the aggressive forces or a decrease in 
the defensive capabilities of the stomach is not clear. A summary of 
these factors is shown in Table 1.2.
Hyperacidity - The theory of Cruveilhier (1840)
According to this theory gastric ulcers are due to an abnormally high 
level of acid secretion by the stomach which overwhelms the mucosal defence.
However, gastric ulcer patients have acid secretion rates within 
the normal range (Wormsley and Grossman, 1968) and antacid therapy has 
been ineffective in accelerating the rate of healing of the gastric 
ulcer (Baume and Hunt, 1969). These findings have led a number of 
authors to conclude that hypersecretion and hyperacidity are not, in 
general, the cause of gastric ulceration.
The observations of Wormsley and Grossman (1968) however, refer to 
gastric ulcer as shown by occidental subjects. A d ifferen t situation , 
in which gastric ulcer is associated with above normal acid secretion 
rates, is found in the Chinese (Fung, 1970). S im ilarly, the finding that 
gastric ulcers may be associated with extreme hypersecretion (greater 
than 10 mEq/hour) as in the Zollinger-Ellison syndrome (E llison and 
Wilson, 1964) and that achlorhydria induced by radiotherapy caused 
temporary healing of gastric ulcers (Rickets et al ,^ 1949) indicate the 
importance of gastric acid in the development of an ulcer.
Antral Stasis Dragstedt Theory
According to this theory the following chain of events occurs: 
hindrance of gastric emptying - antral stasis -  distension -  secretion 
of gastrin in the antrum - hypersecretion - gastric ulcer (Dragstedt, 
1956). More recent observations suggest that this mechanism, although 
theoretically possible, rarely occurs in practice. Delayed emptying and 
stassis may arise as complications of ulcers .located near the pylorus 
but, in such cases, have nothing to do with the pathogenesis of the ulcer 
(Mangold, 1958). Hypergastrinaemia is frequently observed in gastric  
ulcer, but is the result of hyposecretion with a high pH in the antrum 
(James, 1949) and not the cause of hypersecretion (Trudeau, 1971).
Back Diffusion of Hydrogen Ions
In 1933 Teorell found that the gastric mucosa of cats was permeable 
to hydrogen ions which were exchanged for in trace llu la r sodium ions.
He postulated that the ions were exchanged by passive diffusion of 
hydrogen ions. Davenport (1964) demonstrated that damage to the 
mucosa in Heidenhain pouches in dogs caused by acetyl sa licy lic  acid or 
bile  salts caused the hydrogen ion efflux from the lumen to increase.
He showed that a significant level of back diffusion occurred following 
insta lla tion  of an acid solution into the stomachs of gastric ulcer, 
g a s tritic  and hypochlorhydric patients. Similar results were obtained 
when the gastric mucosa was damaged by salicylate treatment (Ivey, 1972) 
and b ile  salts (Den Besten, 1972). I t  has been postulated that an 
abnormally permeable mucosa may exist or can be induced in humans, a 
phenomenon which may explain the apparent achlorhydria frequently 
encountered in gastric ulcer patients (Davenport, 1965; Ivey, 1971).
From these observations i t  may be concluded that the aetiology of 
the gastric ulcer in some patients could be due to back diffusion of 
hydrogen ions through a defective mucosal barrier.
Refux of Bile - Du Plessis Theory
According to Du Plessis (1965) the following chain of events occur: 
pyloric incompetence - reflux of b ile  - damage to mucosal membrane -  
chronic g a stritis  spreading upwards from the pylorus -  development of 
an ulcer in the damaged mucosa.
The evidence in favour of this theory is based on the finding that 
bile  reflux is present in the majority of gastric ulcer patients (Du 
Plessis, 1965) but is rare in normal subjects.
This theory found support from the work of Davenport (1968) and 
Geall (1970) who discovered that b ile  damaged mucosa became freely  
permeable to the movement of hydrogen ions. In the case of massive 
exposure to b ile , e.g. a fte r gastric resection, in trace llu la r mucus 
disappears from superficial cells (van Geertruyden, 1961) and an 
accelerated desquamation occurs (Castrup, 1974). I t  is also worth noting 
that ulcers can be produced more easily in mucosa previously damaged by 
bile than in healthy mucosa (Du P lessis,1965; Stadelmann, 1971).
There is , however, no proof that an incompetent pyloric sphincter 
is the cuase of gastric ulceration, rather than the result. S im ilarly, 
mucosal damage by b ile  has only been demonstrated in acute experiments.
A causal relationship between the obligatory chronic g a s tritis  in ulcer 
and the effect of b ile  is possible (van Geertruyden, 1961) but as yet 
unproven. I t  is equally possible that the observed gas tritis  is a 
consequence of the ulcer rather than the cause.
In addition to b ile  damage of the mucosa i t  has been suggested 
that duodenal reflux plays an important role in the pathogenesis of 
gastric ulcer due to the pancreatic secretions i t  contains (Capper, 1967) 
This hypothesis postulates that pancreatic secretion exposes the ulcer 
site  to proteases which are active at neutral and higher pHs, resulting in 
a continuation of autodigestion at pH levels where peptic digestion is 
impossible.
Stress Ulceration
I t  is well known that severe physical stress (in ju rie s , burns or 
major operations) particularly when associated with blood loss may be 
followed by the development; of acute haemorrhagic gastric mucosal lesions 
(Harjola, 1966; Goodman, 1968).
The pathogenesis of the lesion is not clear but d iffers  from that 
of the chronic gastric ulcer in that the primary aetiological factor 
appears to be a decreased mucosal blood flow (Chui, 1971), presumably 
due to splanchnic vasoconstriction and diversion of blood from the 
mucosa through arteriovenous shunts. Menguy and Masters (1974) have 
suggested that the link between gastric mucosal ischaemia and the eventual 
lesion is a severe disturbance in the energy metabolism of the gastric  
mucosal c e ll.
Treatment of Gastric Ulcer
There are three aims in the management of peptic ulcer, namely, the 
allev ia tion  of symptoms, the healing of the ulcer and the prevention of 
its  recurrence. While there are effective methods for relieving symptoms 
and accelerating ulcer healing there are no means of preventing ulcer 
recurrence, nor of altering the natural tendency to remit and re3apse.
Methods used to a llev ia te  symptoms and accelerate ulcer healing 
include bed rest, alterations to d ie t, cessation of smoking, major surgery 
and drug therapy. Bed rest is undoubtedly the single most effective  
measure fo r the re lie f  of pain and promotion of healing. I t  has been 
shown that reflux of duodenal contents into the stomach is markedly 
lowered in the recumbent position (Capper, 1967; F lin t and Geech, 1970). 
There is also good evidence that stopping smoking accelerates the rate  
of healing of gastric ulcers (Doll et jH_, 1958).
Surgical Treatment
Modern surgical treatment has much to o ffer the patient with 
intractable peptic ulceration. For gastric ulcer the operation of 
choice is a partial gastrecton^y, preferably with a B illro th  I anastomosis,
in which the ulcer i ts e lf  and the ulcer bearing area of the stomach is 
resected. However, major surgery does have certain disadvantages in 
that i t  is irreversible and is prone to complications such as perforation, 
anaemia and nutritional impairment. Drug therapy, on the other hand, 
provides re lie f  and promotes healing with the advantage of minimal, i f  
any, hospitalization and subsequent major surgery.
Drug Therapy ' ' .
The dominance of conventional a lka li and anticholinergic therapy 
in the management of gastric ulceration has been challenged in the las t 
decade by a wide range of newly developed drugs. The l is t  is formidable 
and includes antipepsins and antigastrins, drugs enhancing mucosal 
resistance and ulcer insulation. In addition preparations are available  
which act on corticohypothalamic pathways and gastric m o tility . A 
comprehensive review of gastric anti-secretory and an ti-u lcer agents is 
available (Bass, 1974).
Of particular interest and importance are the group of compounds 
which have a protective effect on the gastric mucosal barrier, thus 
enhancing its  resistance to attack and accelerating the rate of healing 
of the gastric ulcer. This group includes, carbenoxolone sodium 
(Biogastrone), proglumide (Milid,Xylamide) gerapyl farnesylacetate 
(Gefarnate, G efarn il), cholestyramine (Questran) and possibly the E 
type prostaglandins (Fig. 1 .4 ). The drug carbenoxolone sodium is the 
major drug of the group and has been recognised as the most strik ing  
therapeutic advance in the treatment of the disease.
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Figure 1.4 Some Drugs used in the Treatment o f Gastric Ulcers
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1.3 CARBENOXOLONE SODIUM
Carbenoxolone (3-0-[B-carboxypropionyl]-ll-oxo-183-olean-12-en-30- 
oic acid) is the synthetic hemisuccinate of the triterpenoid 18-3- 
glycyrrhetic acid (enoxolone) which is the aglycone of glycyrrhizic  
acid, a substance present in licorice root. I t  is thus a pure synthetic 
derivative of a naturally occurring plant m aterial.
To date there are more than 350 publications on the biochemistry, 
pharmacology and therapeutic evaluations of this product. These have 
been discussed at four symposia (Robson and Sullivan, 1968; Baron and 
Sullivan, 1970; Avery-Jones and Sullivan, 1972 and Avery-Jones and Parke,
1974). A number of review artic les are also available (Sireus, 1972;
Lewis, 1974; Pinder et a/[, 1976).
Pharmacology and Biochemistry
Carbenoxolone has anti-inflammatory properties having about one 
th ird of the a c tiv ity  of cortisol when administered parenterally (Khan, 
1968; Sullivan, 1972). This action is thought to be p a rtia lly  dependent 
on endogenous corticosteroid production. The effects of carbenoxolone 
on corticosteroid levels are not apparent with acute administration 
(Mollman, 1973), but become obvious a fte r prolonged treatment for a month 
or more (Gollan et jH , 1975).
The drug also exhibits an an ti-d iu retic  action with sodium retention  
and potassium depletion. This, the most common adverse reaction in 
carbenoxolone therapy, is manifest only at high dose levels and can be 
kept to a minimum by dietary management of sa lt intake (Banks and Marks, 
1970).
Carbenoxolone is a large highly lipoph ilic  molecule but is nonetheless 
extensively and rapidly absorbed in man a fte r oral administration. An
average level of 15 yg/ml, equivalent to 75% of the dose present in blood, 
is reached within two hours of a 100 mg dose (Baron et £]_, 1975). The 
principal s ite  of absorbtion is thought to be the stomach.
Due to the high degree of protein binding of carbenoxolone to plasma 
proteins, more than 99.95% bound in the dog, rabbit, ra t, rhesus monkey 
and man (Parke and Lindup, 1973), the drug is confined almost en tire ly  to 
the gastrointestinal tra c t, the liv e r  and the plasma. In fact i t  has been 
suggested that there may be protein binding sites in the stomach which have 
a special a f f in ity  for carbenoxolone since [ llfC]carbenoxolone administered 
in traperitoneally migrates back into the gastrointestinal lumen, especially 
the gastric mucosa (Parke, 1972).
In the rat carbenoxolone is extensively metabolised to enoxolone and 
succinate (60-75% of an oral dose) by microfloral hydrolysis and is 
excreted in the b ile , mostly as sulphate and glucuronide conjugates of 
enoxolone (Iveson et al_, 1971). In contrast, man, the squirrel monkey 
and ferrets metabolise carbenoxolone primarily by conjugation to give 
carbenoxolone-30-glucuronide. Hydrolysis of the ester to enoxolone and 
succinate occurs only to a small extent, 10-20% of the dose (Iveson et a l , 
1971, Parke, 1972). In v itro  experiments have shown that rat faeces, 
caecal contents or gastric aspirates readily hydrolysed carbenoxolone 
to glycyrrhetinic acid and succinate, whereas human blood, ra t blood and 
rat liv e r  were incapable of carrying out this reaction (Iveson et a!,1971).
Carbenoxolone in the Treatment of Gastric Ulcer
The f i r s t  controlled t r ia l of carbenoxolone in the treatment of 
gastric ulcer was reported by Doll and his co-workers (1962). SincO then 
tr ia ls  have been conducted in a large number of patients. Reviews by 
Piper and Heap (1972) and Pinder et aj_ (1976) tabulate and discuss the
c lin ica l tr ia ls  carried out on carbenoxolone. They provide good evidence 
for the effectiveness of carbenoxolone in accelerating the rate of gastric 
ulcer healing in the ambulatory patient.
Possible Modes of Action
The precise mode of action of carbenoxolone is unknown. I f ,  however,
the view is accepted that an ulcer results from an upset in the balance
/
between aggressive and defensive forces, a number of possibilites become 
apparent.
Gastric Acid Secretion
Carbenoxolone has equivocal effects on the secretion of gastric acid 
and i t  seems unlikely that they play a role in its  therapeutic actions.
In rats Gheorgiu and his co-workers (1971) found that although the total 
volume of the gastric juices was decreased a fte r carbenoxolone administration 
(100 mg/kg) the acid output was unchanged. In contrast (Henman, 1970) 
observed a reduction of total acidity in anaesthetised pylorus ligated rats .
S im ilarly , the results of studies in man are inconclusive. Only s ligh t 
and insignificant changes in acid production have been noted by some authors 
a fte r carbenoxolone treatment in normal subjects (Berstad et a^, 1970;
Ivey and Gray, 1973a)and in gastric ulcer patients (Bersted, 1972; Domschke 
et al_, 1972). On the other hand Banks et al_ (1967) noted a reduction of 
34% in maximal acid output a fte r two weeks of therapy at a dose of 300 mg 
daily .
I t  is of in terest to note that Rooney et al_ (1974) found higher levels 
of serum-immunoreactive secretin in patients treated with carbenoxolone. 
Secretin inhibits both the secretion and metabolic actions of gastrin , 
which i ts e lf  is involved in mediating cell pro liferation and stimulating 
acid secretion.
Back Diffusion of Hydrogen Ions
As with acid secretion reports on the effects of carbenoxolone on 
the back diffusion of hydrogen ions are conflicting. Colin-Jones and 
Taylor (1973) demonstrated that carbenoxolone treatment decreased ionic 
movement by about 30% in gastric ulcer patients. However, Ivey and Gray 
(1973a, b) could detect no significant influence of the drug on ionic 
fluxes in normal subjects receiving taurocholic acid or hydrochloric 
acid liquid meal tests. Their results, however, although not significant 
showed the same trends as those of Colin-Jones and Taylor (1973) where 
findings were obtained using a larger group.
Carbenoxolone has also been shown to prevent the significant increase 
in back diffusion caused by large doses of prednisolone (Domschke et a l ,
1975), and in dogs with Heidenhain pouches the back diffusion normally 
associated with b ile  injury was prevented (Cross and Rhodes, 1972;
Calcraft et al_, 1974).
Bile Reflux
Dippy (1973) in a study of 26 gastric ulcer patients found that 
carbenoxolone had no effect on the degree of b ile  reflux. This finding  
has now been challenged by Fisher and Larber (1975) who, using the more 
modern technique of measuring intraluminal potential difference and 
pyloric pressure, found that carbenoxolone may effect the degree of b ile  
reflux in some patients.
Peptic Digestion
Berstad (1972) showed in both in vivo and in v itro  studies that 
carbenoxolone was capable of reducing the peptic ac tiv ity  of human gastric  
ju ice . In vivo the inhibition was apparent for 40 to 60 minutes from the
time of dosing. Other studies in man have fa iled  to confirm the results 
of Berstad, when oral rather than intragastric administration was used 
(Domschke et £j_, 1972a; Hausman and Tarnoky, 1966).
Walker and Taylor (1975a,b) established that successful carbenoxolone 
therapy was associated with a fa ll  in total pepsin secretion in response 
to pentagastrin. They also noted a reduction in pepsin and an in a b ility  
to sustain pepsin secretion.
In animal studies Henman (1970) observed a dose dependent inhib ition  
of peptic a c tiv ity  by carbenoxolone. These results have been recently 
confirmed (Birnbaum and Karmeli, 1975). In this study carbenoxolone 
protected animals against the effects of taurocholic acid or aspirin and 
peptic ac tiv ity  was reduced by between 34% and 82%.
Thus i t  would appear that carbenoxolone induces a decrease in peptic 
a c tiv ity  in v itro  and in vivo. This effect could be mediated in several 
ways:-
(1) Irreversible inactivation of pepsinogens in mucosal cells .
(2) Irreversible inactivation of pepsin in the lumen,
(3) Binding of pepsin in the lumen and thereby reducing its  effective
concentration*.
This la tte r  action is particu larly  feasible since pepsin is an 
albumin lik e  protein, and the very strong a f f in ity  of carbenoxolone for 
albumin has been amply demonstrated (Parke and Lindup, 1973).
Mucosal Cell Turnover
The pathogenesis of the gastric ulcer involves an acceleration in 
the rate of DNA synthesis and ep ithelia l cell turnover (Lipkin, 1971).
In mice carbenoxolone treatment caused a 50% increase in the lifespan of
, i
mucosal cells and a corresponding decrease in the rate of DNA synthesis.
This effect has been confirmed in the human gastric mucosa (C roft, 1973;
Klein e ta ^ , 1975). The number of mitoses decreased with treatment but 
the effect was lim ited to the ulcer regeneration zone and was not present 
in normal tissue.
i
Mucus Synthesis
Increased mucus production has been noted in patients following 
carbenoxolone treatment, both in gastric aspirates and surgical observations. 
This finding has been reported for normal subjects (Hausmann and Tarnoky,
1966) and for chronic gastric ulcer patients (Goodier et al ,^ 1967, 1968). 
Goodier (1968) observed an abundance of PAS-positive mucosubstance a fte r  
only 4 days of treatment. Neutral mucosubstance was adherent to both the 
gastric mucosa and to the crater of the healing ulcer.
This increase in gastric mucus synthesis a fte r carbenoxolone treatment
has been confirmed in studies on rats (Dean, 1968; Gheorgiu e t al_, 1972;
Yeomans and St. John, 1974; Berg et al_, 1975), guinea pigs (Lipkin and
Ludwig, 1968), cats (Johnson, 1968) and dogs (Cross and Rhodes, 1972;
i
Calcraft et aT[, 1974).
As well as increasing the volume of mucus secreted, there is evidence 
that carbenoxolone causes the production of a chemically modified glyco­
protein (Domschke et al_, 1972a,b). Parke (1972) has suggested that this  
could be mediated by the binding of the drug to functional proteins such 
as the nuclear histones. In man and rats Gheorgiu and his co-workers (1972) 
found that the N-acetylneuraminic acid (NANA) and hexosamine content of the 
gastric glycoprotein was elevated following carbenoxolone treatment.
Yeomans and St. John (1974) found no increase in the s ia lic  acid 
content of rat gastric mucosal glycoprotein a fte r carbenoxolone treatment
but Domschke et aT_ (1972a,b) found that in gastric ulcer patients NANA 
levels were depressed but became elevated a fte r 4 weeks of carbenoxolone 
therapy. From these findings they proposed that NANA plays an important 
role in the protective function of mucus.
Following treatment of rats with carbenoxolone, Shillingford et al 
(1973) observed increased mucosal concentrations of hexosamines, fucose 
and s ia lic  acids and an increase in the a c tiv ity  of gastric UDP-glucuronyl 
transferase. They also found (Shillingford et al_, 1974) an increase in 
the rate of incorporation of N-acetylglucosamine, glucosamine, galactose, 
galactosamine, s ia lic  acid and fucose into glycoproteins.
Further work by the same group (Johnston jet al_, 1975) has shown that 
the rate of incorporation of N-acetylglucosamine is markedly reduced in 
disease states such as gastric ulcer and g a s tr itis . After treatment with 
carbenoxolone the c lin ica l pattern of healing was accompanied by marked 
increases in the rate of incorporation.
I t  seems lik e ly  that gastric ulcer involves, at least in part, an 
impairment of the synthesis of glycoproteins necessary fo r the functioning 
of the gastric mucosal barrier. Carbenoxolone appears to exert a major 
action by restoring mucus synthesis to normal and perhaps modifying this  
synthesis to produce a more protective glycoprotein. The results of thse 
alterations would inevitably be a stronger and more resistant gastric  
mucosal barrier.
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1.4 AIM OF PROJECT
The aim of this project is to develop in v itro  systems 
for studying the synthesis of gastric mucosal glycoprotein.
To use these systems in determining the effects of ulcerogenic 
stimuli and anti-ulcerogenic drugs on mucus synthesis in 
human and animal gastric mucosae with a view to gaining 
insight into the pathogenesis of the gastric ulcer and the 
mode of action of anti-u lcer drugs. Furthermore, in view 
of the possible involvement of lysosomes in ulcerogenesis to 
study the effects of carbenoxolone sodium on lysosomal membrane 
s ta b ility .
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CHAPTER TWO
GLYCOPROTEIN SYNTHESIS IN RAT, FERRET AND HUMAN 
GASTRIC MUCOSAE
2.1 INTRODUCTION
To understand the molecular interactions involved in the gelling  
and viscous properties of mucus, which are responsible for its  protective 
and lubricating functions, requires a knowledge of its  molecular components, 
the ir structure and behaviour. Glycoproteins, the principal constituents 
of mucus (Spiro, 1 9 7 0 ) ,  can be simply regarded as proteins which have 
carbohydrate covalently bound to the ir peptide core. They are widely 
distributed in nature, occurring not only in vertebrate and invertebrate 
animals but also in plants, unicellular organisms and viruses. The 
functions of these compounds are many and varied. As well as having a 
protective role they act as transport, immunoprotetive, hormonal and 
structural agents in various tissues.
The amino acid composition of gastric mucosal glycoprotein is 
characterised by a high content of threonine, serine, proline, alanine 
and glycine and very low concentrations of aromatic and sulphur-containing 
amino acids. The composition of the "human principal gastric glycoprotein" 
(Schrager, 1969) is shown in Table 2.1.
The sugars which have been found in the carbohydrate portion of the 
mucous glycoproteins are N-acetylglucosamine, N-acetylgalactosamine, 
galactose, fucose and N-acetyl neuraminic acid (Schrager, 1969). The 
four main sugar components found in human gastric glycoprotein, N-acetyl-  
glucosamine, N-acetylgalactosamine, galactose and fucose exist in the ra tio  of 
3:1:4 :2 (Oates eta l_ , 1974).
Attachment of the carbohydrate to the peptide portion of the glyco­
protein involves a link between the C-l carbon of the most internal sugar 
residue and a functional group of an amino acid within the peptide chain.
Table 2.1 Composition of Principal Gastric Glycoprotein
Components
Aspartic acid
Threonine
Serine
Glutamic acid
Proline
Glycine
Alanine
Valine
\ Cystine
Methionine
Isoleucine
Leucine
Tyrosine
Phenylalanine
Lysine
Histidine
Arginine
Glucose
Mannose
Galactose
Fucose
S ialic  acids 
Glucosamine 
Galactosamine 
Total hexosamine 
Total neutral sugar 
Sulphate
Concentration 
(mol/mol glycoprotein)
52
580
296
87
418
120
210
58
trace
0
41
81
17
41
29
52
52
0
0
3596
2376
133
2726
928
3654
5972
128
(From Schrager, 1969)
Because of the high proportion of serine and threonine in the peptide 
chain and sim ilar number of N-acetylgalactosamine residues in the 
carbohydrate side chains i t  is believed that 'O' glycosidic linkages 
between these residues jo in  the carbohydrate to the protein core.
Moreover, studies employing a-N-acetylgalactosaminidase have shown this  
link to be a in anomeric configuration in hog gastric mucus 
(Weissmann and Henrichsen, 1969).
As yet the amino acid sequence around the amino acid residue 
involved in the glycosidic linkage has not been elucidated for mucus 
glycoproteins. In the case of other glycoproteins, e.g. immunoglobulins 
however where asparagine is the linking amino acid, the structure 
Asn-x-Thr(or Ser), where x is any amino acid is thought to be necessary 
for glycosylation to occur (Neuberger and Marshall, 1969). Such a 
structure may be necessary as a recognition sign for an enzyme attaching 
the f i r s t  sugar residue of the carbohydrate chain.
Oates and his co-workers (1974) have studied.the structure of the 
carbohydrate side chain o f human gastric mucus glycoprotein carrying 
blood group H a c tiv ity . Their studies indicate that a large number of 
carbohydrate chains (carrying numerous side chains of varying length) 
are attached to serine and threonine units of the protein through 
N-acetylgalactosamine residues. The carbohydrate chains are thought 
to be mainly alternating sequences of galactose linked to N-acetylglucosamine 
with fucose present at the end of the chain and also at branching points.
F ifty  to seventy percent of the serine and threonine residues of the 
polypeptide chain are involved in glycosidic linkages (Tanaka and Pigman, 
1965) indicating a very close spacing of carbohydrate chains along the 
polypeptide. In porcine submaxi 11ary mucin there is an average of one 
carbohydrate chain per eight amino acid residues (Carlson, 1968). I t  is
believed that the close spacing of the carbohydrate groups containing 
negatively charged residues such as s ia lic  acid may be responsible for 
the high viscosity of mucus (Gottschalk, 1960).
Interest in the chemistry and structure of glycoproteins has been 
stimulated by the demonstration that many mucus glycoproteins contain 
antigens, which in common with those of the erythrocyte cell surface 
belong to the A B H and Lewis blood group system (Watkins, 1972).
Foremost among the blood group active glycoproteins examined have 
been those isolated from ovarian qyst flu id  in which i t  is evident that 
blood group a c tiv ity  is determined by terminal sugar substituents in 
the form of galactose, N-acetylgalactosamine and fucose linked to the 
carbohydrate chain core.(Watkins, 1966). Figure 2.1 shows the structures 
of the immunological determinants of A B H and Lewis blood group
ac tiv itie s  in ovarian cyst glycoprotein. These structures have been 
confirmed by the work of Oates et al, (1974) for human gastric glyco­
protein.
I t  is of interest to note that while s ia lic  acid substituents occur 
as terminal substituents in the carbohydrate of A B H and Lewis blood 
group active glycoproteins this sugar does not have an antigenically  
determining role and indeed its  removal often permits enhanced re ac tiv ity  
(Baig and Aminoff, 1972).
The presence of a sulphated glycoprotein has been established in the 
hog gastric mucosa (Slomiany and Meyer, 1972; Liau and Horowitz, 1974). 
This glycoprotein, which possesses both A and H blood group a c tiv itie s  
is sulphated by an ester link through N-acetylglucosamine. The structure 
of the sulphated carbohydrate chain of this glycoprotein has been
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Figure 2.1
Blood Group 
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determined by Slomiany and Meyer (1973) and is shown in Figure 2.2.
The presence of endogenous sulphated glycoprotein in human gastric 
mucus has not, however, been positively demonstrated (Lambert and 
Andre, 1972).
L it t le  is known of the secondary structure of gastric muco- 
substances although i t  is lik e ly  that they have a 'bottle  brush' 
structure sim ilar to that proposed for the blood group substances 
(Morgan, 1959) with a core of protein and side chains of carbohydrate. 
This concept is supported by the work of Bettleheim (1963) whose 
infra-red studies on bovine submaxi 11ary glycoprotein demonstrated 
that the carbohydrate side chains appeared to be at right angles 
to the polypeptide.
Allen and Snary (1972) have studied the structure o f glycoproteins 
of soluble mucus from the cardiac region of the pig stomach. Two
c
glycoprotein fractions, A (molecular weight 2 x 10 ) and B (molecular
5
weight 1.1 x 10 ) were isolated. S im ilarities in chemical analysis, 
blood group a c tiv ities  (A and H) and biosynthetic patterns (Snary and 
Allen, 1971, 1972) led these authors to conclude that low molecular 
weight glycoprotein B was a repeating unit of glycoprotein A, this 
molecule being a discrete assembly of about 18 glycoprotein B units 
joined covalently. Furthermore treatment of glycoproteins A and B 
with mercaptoethanol, which breaks disulphide bridges s p lit  both
c
glycoproteins into four subunits of molecular weight 5.2 x 10 for 
glycoprotein A and 2.8 x 104 for glycoprotein B (Starkey et aT, 1974).
Thus a picture of the highly polymeric structure of mucoproteins, 
necessary for their viscous properties, can be obtained. The basic
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subunit of the glycoprotein has a molecular weight of about 28,000. 
Four of these units are joined by disulphide bridges to form the 
low molecular weight mucoprotein B of the water soluble mucus. 
Mucoprotein B in turn is polymerised to form the high molecular 
weight mucoprotein A in such a way that A is also composed of four 
subunits joined by disulphide linkages. A diagrammatic representation
i
of this molecule is shown in Figure 2.3.
Biosynthesis of glycoproteins
I t  has been concluded from studies using classical inhibitors  
of protein synthesis (Spiro and Spiro, 1966), and from the auto- 
radiographical demonstration of localization of growing polypeptide 
chains around the polysomes (Neutra and Leblond, 1966), that bio­
synthesis of the protein fraction of the glycoprotein takes place 
before and occurs independently of carbohydrate attachment.
Once incorporated into the polypeptide chains of mucus glyco­
protein the amino acids serine and threonine may be glycosylated.
The addition of the f i r s t  carbohydrate unit to the peptide chain 
and subsequent elongation of the carbohydrate chain is affected by a 
group of enzymes known as the glycosyl transferases. These enzymes 
catalyse the transfer of sugar residues from sugar nucleotide donors, 
(UDP-galactose, UDP N-acetylglucosamine, UDP N-acetylgalactosamine, 
CMP-N-acetylneuraminic acid and GDP fucose) to the polypeptide or 
growing carbohydrate chains as the glycoprotein moves from the rough 
endoplasmic reticulum to the smooth endoplasmic reticulum and Golgi 
complex. Evidence exists that glycosylation may occur even before the 
polypeptide chain has le f t  the ribosome (Lawford and Schachter, 1967; 
Louisot _et a l , 1967).
Fi
g.
 
2.3
 
A 
di
ag
ra
m
at
ic
 
re
pr
es
en
ta
tio
n 
of 
the
 
fo
ur
 
gl
yc
op
ro
te
in
 
su
bu
ni
ts
 
jo
in
ed
 
to 
for
m 
the
 
ga
st
ric
 
gl
yc
op
ro
te
in
O
S- o
Q .
4->
O
CO
CO*o
*0 *r*
<D S-
4-> QJ jQ  fd S- 
r—  O  OJ>> u -o
— (/>—W- -w-w — -w-w-
0  •!— CL 
> >  CD «—  r— 4-> 3  
CD O  CO
1 S- - r -C 0.-0
W - C / l  -  W - W
Experimental evidence suggests that differences occur in the sub-cellular 
distribution of the glycosyltransferases. Thus Bouchilloux et al^  (1970) 
found that the rough endoplasmic reticulum of sheep thyroid is enriched 
in enzymes required to transfer the internal sugars, N-acetylglucosamine 
and mannose, whereas the Golgi-rich fractions could transfer galactose 
and N-acetylglucosamine to more external positions of thyroglobulin 
precursors. S im ilarly, a ll three enzymes that catalyse the transfer 
of s ia lic  acid, galactose and N-acetylglucosamine to form the terminal 
trisaccharide of plasma proteins have been found to be concentrated in 
the Golgi fraction of ra t liv e r  (Schachter, j i t  al ,^ 1970).
i
The exact mechanism involved in determining completion of the 
polysaccharide chain and transportation of the glycoprotein molecule 
remains unknown. I t  has been proposed that the addition of a specific  
sugar residue(fucose, NANA) or of a specific steric configuration such 
as the a- D-configuration of N-acetylgalactosamine and D-galactose in 
human blood group A and B substances respectively may stop any further 
incorporation of sugar components (Gottschalk, 1969).
L itt le  is known of the d ifferent phenomena contributing to the 
regulation of glycoprotein biosynthesis. Whereas synthesis of the 
protein core is under direct genetic control, glyCosylation is  not.
I t  is subject to the influence of enzyme specific ity  and substrate 
and cofactor a v a ila b ility . The various stages of carbohydrate attachment 
therefore stand out as logical points for rapid physiological control and 
could also be the loci where pathological processes could operate to 
influence the rate of synthesis or the nature of the product formed.
The high specific ity  of the glycosyl transferases, towards both 
the sugar nucleotide and the acceptor, permits the synthesis of complex 
carbohydrate units with structures defined in regard to sequence and
branching as well as position and anomeric configuration of the 
linkages. Acceptor specific ity  has been shown for a fucosyltransferase 
from ra t small intestinal mucosa (Bella and Kim, 1971). This enzyme 
was shown to be active in transferring fucose to a terminal galactose 
residue of a glycoprotein or oligosaccharide when galactose was linked 
by a B-glycosidic bond to the next sugar. S im ilarly, Tuppy and 
Schenkel-Brunner (1969) found that the requirements for N-acetylgalactos- 
aminyltransferase and galactosyl transferase from pig stomach were 
identical except in their donor s p ec ific ities , one requiring UDP 
N-acetylgalactosamine and the other UDP-galactose.
Although regulation of glycosylation is  not under nucleic acid 
template control i t  is under genetic control insofar as the synthesis 
of the transferase enzymes is template controlled. Thus a-D galactosyl- 
transferase which transfer D-galactose in a linkage to the terminal 
galactose of blood group H active glycoproteins, conferring group 
antigenicity were found to be absent in tissues from A or 0 group 
donors (Poretz and Watkins, 1972), implying that the gene coding for 
this enzyme is absent or inoperative in these groups. I t  is of 
interest to note that the incidence of gastric ulcer is high among 
blood group 0 subjects.
I t  has also been suggested that the subcellular distribution of 
the glycosyltransferases could play a role in the control of glycoprotein 
synthesis (Schachter, 1974). Thus the localisation of N-acetylneuraminyl- 
transferase in the Golgi complex would preclude N-acetylneuraminic acid 
from appearing in the carbohydrate chain anywhere other than in terminal 
positions (Schachter et a l ,  1970).
Catabolism of glycoproteins is thought to occur mainly in the 
lysosomes (Aronson and De Duve, 1968; Mahadevan et_ al_, 1969). These 
subcellular organelles contain glycosidases specific for almost every 
sugar and anomeric configuration occurring in glycoproteins (Patel 
and Tappel, 1971). The breakdown of glycoproteins by lysosomal 
hydrolases is discussed in Chapter 4.
The precise means by which gastric mucus exerts its  protective 
action is unknown. The high viscosity of mucus has been accepted 
as an important protective feature (Rainsford, 1975). This high 
viscosity has been attributed to the a b ility  of the mucus glycoproteins 
to form high molecular weight complexes (Starkey et jH , 1974),to the 
close spacing of the carbohydrate chains along the polypeptide core 
(Carlson, 1968) and to the presence of acidic groups, such as s ia lic  
acid and possibly sulphate moeities (Gottschalk and Thomas, 1961). 
Domschke and his co-workers (1972) found NANA levels depressed in mucus 
from gastric ulcer patients.
As well as a possible role maintaining the viscosity of gastric  
mucus i t  has been suggested that sulphated glycoproteins may protect 
the mucosa through an anti-peptic e ffect (Prino et al_, 1972).
The Effects of Drugs and Disease States on the Synthesis of Mucus
Histological, biosynthetic and chemical analysis studies have 
demonstrated that pathological conditions and drug therapy may be 
associated with changes in the amount of mucus secreted and/or in the 
quantitative relationships of glycoprotein components.
Of the drugs associated with gastric damage the most widely studied 
with respect to mucus synthesis are aspirin and sodium sa licy la te . A
review of the biochemical pathology of aspirin-induced gastric damage 
has recently been published (Rainsford, 1975). Histochemical studies 
and chemical analyses have shown that repeated administration of 
salicylates results in a reduction in the quantity of the sulphate 
and carbohydrate components of gastric mucus in the ra t (Menguy and 
Masters, 1965; Ganter et al ,^ 1966; Johannson and Linquist, 1970) and 
dog (Hakkinen et £l^, 1968; Lev et £]_, 1972). Moreover, biosynthetic 
studies have shown aspirin to in h ib it the uptake of [^Cjglucose 
(Kent and Allen, 1968) and 3^S0^"" (Rainsford, 1975).
Phenylbutazone has been shown to cause changes in the carbohydrate 
to protein ratios in the dog stomach, with a decrease in the s ia lic  
acid, fucose and hexosamine content of the mucus (Menguy and Desbaillets,
1967). Similar findings are reported for the ra t stomach (Takagi and 
Abe, 1974). Similar results have also been obtained for cortisone 
(Menguy and Masters, 1963) and ACTH (Desbaillets and Menguy, 1967) in 
dog stomach and for prednisolone (Roberts and Mezami, 1963) in the ra t.
Other factors having an adverse effect on the gastric mucosa include 
stress due to cold, water immersion, restra in t stress (Takagi and Yano,
i
1972) and starvation (Menguy, 1969). These have been shown to decrease 
the hexosamine content of ra t gastric mucus and Lambert et al (1970) 
have shown a decrease in the incorporation of radiosulphate in restrained 
rats.
In pathological conditions of the human gut alterations in mucus 
synthesis have also been observed. In ulcerative c o lit is  there is a 
significant increase in mannose containing glycoprotein (Teague e t a l ,
1973) and mucusvglycoprotein from gastric ulcer patients has a s ign ifican tly  
reduced N-acetylneuraminic acid content (Domschke et a l , 1972).
Gastric carcinoma is associated with an alteration in the quantitative  
relationships between the sugar components of the carbohydrate chains of 
mucus glycoprotein (Schrager and Oates, 1973). These authors also found 
a change in blood group specific ity  of the glycoproteins from cancerous 
cells compared with that of the hosts red blood ce lls .
The role of sulphated glycoproteins in human gastric mucus is a 
subject of controversy. Lambert and Andre(1972) have suggested that 
unlike the dog (Ley et al_, 1969), pig and ra t (Rainsford, 1975) the 
normal human adult gastric mucosa does not secrete sulphated glycoproteins 
and that their presence in gastric ju ice is due to contamination by saliva 
and bronchial secretions. In pathological conditions such as gastric 
carcinoma, however, the situation appears to be d ifferen t and sulphated 
glycoproteins are secreted both by the tumour and surrounding tissue 
(Lev, 1970; Gad, 1969).
Modifications in the synthesis and secretion of glycoproteins may 
also be affected by drugs which are beneficial in the treatment of gastric  
lesions. Carbenoxolone sodium (Goodier 1967, 1968) the prostaglandin 
analogue I5(R )15 methyl-Eg-methyl ester (Fung et aj[, 1974), zolimidine 
(Cel 1 i eit a]_, 1975), glutamine, gefarnate and sodium copper chlorphylline 
(Takagi and Yano, 1972) have been shown to increase the rate of synthesis 
of gastric mucin. Moreover, carbenoxolone has been shown to increase 
the amount of protein bound hexosamines and s ia lic  acids in mucins from 
rat and human stomachs (Shillingford et al_, 1973; Gheorghiu e t al_, 1972; 
Domschke et al_, 1972).
This chapter contains details of studies carried out to determine 
the effects of the anti-ulcerogenic drug, carbenoxolone and a mucosal 
damaging drug, ethanol, on glycoprotein synthesis in ra t and fe rre t
stomachs, glycoprotein synthesis being measured by the rate of 
uptake of radiolabelled precursors into an acid precipitable fraction  
of gastric discs. Using this same system the effects of drugs and 
disease on glycoprotein synthesis has been studied in the human 
stomach.
2.2 MATERIALS AND METHODS
Chemicals
Carbenoxolone sodium was a g i f t  from Biorex Laboratories L td ., 
London. All radiochemicals used (Table 2.2) were obtained from the 
Radiochemical Centre, Amersham. Scintillation chemicals were purchased 
from the Packard Instrument Company. A ll other chemicals were Analar 
grade wherever possible and were supplied by either British Drug Houses 
Ltd ., Poole, or the Sigma Chemical Co., London.
Animals
Female Wistar albino rats (200 g ), derived from the Porton strain  
were developed at the Laboratory Animals Centre, Carshalton, and bred 
in the University of Surrey Animal Unit. The animals were housed in 
groups of three to six and were allowed food (Spratts Laboratory Diet 
No. 1) and water ad lib itum , except where specified.
Male ferrets (approximately 1 kg) were purchased from reputable 
dealers for the study. The animals were housed in pairs in the 
University of Surrey Animal Unit. They were fed on a d iet of 'Bounce' 
dog food, dead mice and milk and were allowed water ad lib itum .
Incorporation of Radiolabelled Precursors into Acid Precipitable Fraction 
of Gastric Discs
The technique used was that of Lukie and Forstner (1972) as modified 
for gastric tissue by Shillingford (1975). Rats were k illed  by cervical 
dislocation and the stomachs immediately placed in ice cold KC1 (1.15% 
w/v ) .  Each stomach was opened along the greater curvature and washed 
free of its  contents with ice cold saline. Stomach resections were taken 
from the pyloric antrum using a 14 mm diameter cork borer, the stomach
Table 2.2 Radioactively Labelled Compounds
Compound
N-acety1-D- [1 - 3H]glucosami ne
o
D-[6-  Hjglucosamine 
D -[l-^ C ] galactose
D-[1-3H]fucose
r 14-.N -acety l-[4 ,5 ,6 ,798 ,9 - CJneuraminic acid
L-[G-3H] proline
L -[3 -3Hj serine
L-[G-3H]asparagine
L-fG-^C] threonine
Sodium- [ f 3C]sulphate 
D- [1-^Hj galactose
Specific A ctiv ity  
4.0 Ci/mmol
12.6 Ci/mmol 
59.0 mCi/mmol 
3.61 Ci/mmol
262.0 mCi/mmol
500.0 mCi/mmol
5.3 Ci/mmol
100.0 mCi/mmol
232.0 mCi/mmol
70.6 mCi/mmol
5,2 Ci/mmol
f i r s t  being gently stretched out on a cork dissection board. A sim ilar 
procedure was used in the preparation of discs from the fe rre t stomach. 
These animals were k illed  by COg suffocation rather than cervical 
dislocation.
Stomach discs were placed in 20 ml stoppered test tubes containing 
incubation medium, and preincubated for 10 min at 37°C in a Mickle 
shaking incubator at 100 cycles/min. Incorporation was begun by the 
addition of labelled precursor (0.25-2.5 yCi in 0.1 ml 0.9% w/v NaCl).
The radiolabelled materials were used as follows: N-acetyl |5h] glucosamine,
3 141 yCi (2.5 yCi in ethanol study);f Hjglucosamine, 1 y C i; [  Cjgalactose,
•14 30.5 yCi; N-acetyl [  Cjneuraminic acid, 0.25 yCi; f Hjfucose, 0.5 yCi;
amino acids, 0.5 y C i; [35s]NagS04 , 1 yCi.
The fin a l volume of medium was 2 ml and contained 236 ymol, NaCl;
11.2 ymol KC1; 6.0 ymol CaClg; 2.8 ymol KHgPO^ ; 2.8 ymol MgSO ,^ 58.6 ymol 
NaHCOgj amd 16 ymol 1-glutamine. Tubes were flushed with Og-COg (95-5 v/v )  
every 10 min.
Incubation periods were between l*5h and 6h and were terminated by 
draining the medium and washing the gastric discs twice with ice cold 
saline.
i
Isolation of the Glycoprotein Fraction
( i )  Acid precip itation. Washed gastric sections were homogenised
in 5 mM EDTA (pH 7 .4 , 20 ml) with a Polytron homogeniser and glycoproteins 
were precipitated by storage at 4°C a fte r addition of an equal volume
of trichloroacetic acid: phosphotungstic acid mixture ( 20% w/v : 2% w/v ) .
The acid precipitated fraction was collected by centrifugation at 200 g
for 10 min. The precipitate was washed twice with d is tille d  water and 
contaminating lip id  material removed by two extractions with chloroform- 
methanol (1:1 v/v ) .  The material was then a ir  dried.
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( i i )  Cetylpyridinium chloride precip itation. Washed gastric sections 
were homogenised in 10 ml d is tille d  water using a Polytron homogeniser.
The homogenates were then digested by twice-crystallised pepsin (2 mg/ml) 
at pH 1.6 for 24h at 37°C. The pH was then increased to 7.5 by the 
addition of lM-NaOH and glycoproteins precipitated by the addition of 
cetylpyridinium chloride (fin a l concentration 1% w/v ) .  The precipitate  
so formed was allowed to aggregate overnight at pH 7.5 at room 
temperature and separated by centrifugation. The precipitate was washed, 
extracted for lip ids and dried as described above.
Determination of Radioactivity. The dried glycoprotein fractions were 
weighed into sc in tilla tio n  vials and suspended in d is tille d  water(0.5 m l). 
Perchloric acid (0.3 ml, 60% w/v ) was added, followed a fte r a 10 min 
interval by hydrogen peroxide (0.6 ml, 100 vo ls). The via ls were then 
sealed with plastic liners and screw caps and were heated at 70°C for 
90 min with occasional agitation. On cooling 15 ml s c in tilla to r  
(toluene-Triton X-100, 2:1 v/v ; PP0 0.55% w/v ) was added to each vial 
which was then thoroughly mixed.
S c in tilla tio n  counting of radioactivity was carried out using a 
Packard Tri-Carb Spectrometer (Model 3320) using the internal standard­
ization method for determining counting efficiency.
Examination of the Effects of Drugs. The effects of drugs j j i  vivo 
on the in v itro  incorporation system were determined by pretreatment 
of animals with the drug in a suitable vehicle, control animals 
receiving vehicle only. Details of the compounds, dose levels and 
length of the dosing period are given in the 'Experimental Results' 
section.
Incorporation o f Radiolabelled Sugar into Human Gstric Mucosal Glycoprotein
Human gastric biopsy samples were obtained during gastroscopic 
investigation of patients showing symptoms of gastrointestinal disorder.
The endoscopic procedure was as follows: Patients were given a pre­
operative dose of Buscopam (hyocine N-butylbromide) to reduce secretion 
and relax gastrointestinal musculature, and were anaesthetised by 
intravenous injection of Valium until amnesic but semi-conscious. The 
pharynx having been anaesthetised with a lignocaine spray the endoscope 
was eased into the oesophagus and gently pushed through into the stomach. 
Tissue biopsy samples were obtained using controlled forceps which 
removed approximately 100 mg of tissue. Two such bippsies were taken 
from the lesser curve, greater curve and antrum, from each stomach.
The samples were placed immediately in stoppered tubes containing 
2 ml of incubation medium at 0°C and stored in an ice bath un til incubation 
could be carried out. The time between sampling and incubation was never 
more than two hours.
The incorporation assay used was identical to that used for gastric  
sections. The small tissue samples a fte r incubation being homogenised 
in 5.0 ml EDTA (5 mM, pH 7.4) and glycoproteins precipitated by the 
addition o f 5 ml trichloroacetic acid-phosphotungstic acid (20%:2% w/v ) .
True normal samples from volunteer subjects were not obtained for 
ethical reasons. Instead 'apparent normals1 i .e .  samples from those 
patients with macroscopically normal stomachs as viewed through the 
endoscope, were used.
2.3 EXPERIMENTAL AND RESULTS
Using this incorporation system i t  was shown that a fte r  an in it ia l  
lag phase the uptake of N-acetylglucosamine into the acid precipitated  
fraction was linear at least until the fourth hour o f incubation 
(Figure 2 .3 ), could be inhibited by cycloheximide (10”^M), a classical 
inh ib itor of protein synthesis (Figure 2.3) and had an optimum N-acetyl- 
glucosamine concentration of 25 mM (Figure 2 .4 ). However, i t  was decided 
to work a t sub-optimal concentrations of substrate since achievement of 
optimal concentrations by d ilution of labelled substrate with unlabelled 
substrate reduced the specific ac tiv ity  of the precipitated glycoproteins 
to an unacceptable level (Figure 2 .5 ).
Effect of Carbenoxolone on the Incorporation of Labelled Precursors 
into Rat Gastric Discs
The incorporation of N -acetyl-[3H]glucosamine,[3H ]serine,[^C ]
3 5
threonine and SO^  into the precipitable fraction o f gastric discs 
from rats treated for 7 days with carbenoxolone (25 mg/kg/day) was 
carried out. Control animals received drinking water lonly. The 
results of these studies are shown in Table 2.3.
Carbenoxolone pretreatment had a significant effect on the uptake 
of N-acetylglucosamine, an increase of 71% over the controls being 
observed but did not cause a significant change in the incorporation 
rate of the amino acids, serine and threonine. There was, however, a 
trend towards an increase in uptake particu larly  of threonine.
Significant changes in the rate of incorporation of sodium[3^S] 
sulphate were seen, both in the fraction precipitated by acid ( 100% 
increase) and cetylpyridinium chloride (CPC) (110% increase). The
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Fig. 2.3 Effect o f cycloheximide (ICf^M) on the incorporation of
N-acetylglucosamine into an acid precipi table fraction
of ra t gastric  discs
1 2 3 4 5 6
Incubation Time (h)
Results are means ± SEM of four samples. Closed circles represent 
control discs, open circles treated discs.
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Fig. 2.4 E ffec t o f N-acetylg lucosanine concn on the incorporation o f N -acety1-f3Hl
glucosamine in to  ah acid p rec ip itab le  fra c tion  o f ra t  gas tric  discs
Results are the means ± SEM of four observations.
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Fig. 2.5 Effect of N-acetylglucosamine concn on the incorporation o f N -acetyl-
T^Hl-glucosamine into an acid precipitable frac tion  of ra t gastric  discs
Results are the means ± SEM of four observations.
Table 2.3 The Effects of Carbenoxolone on the Rate of
Incorporation of Radiolabelled Precursors into 
a Precipitable Fraction of Rat Gastric Discs
Precursor Method of precipitation Incorporation rate Change from
mmol x 10~12/mg control
glycoprotein/h % !
Control Carbenoxolone
treated
-3N -acety l-[ Hjglucosamine Acid 3 2 + 8  (6 ) 5 5 + 6  (6 ) * + 71%
[^H] serine Acid 6 2 + 9  (5) 74 + 13(5)N.S. + m
[^Cjthreonine Acid 1260 + 172 (5) 1990+440(5)N.S. + $7%
[35S]-Na2S04 Acid 7 + 1 (6 ) 1 4 + 1  (6 ) * * +100%
L35S]-Na2S04 CPC 3609 + 473 (6 ) 7590+205(6)** +110%
Results are expressed as means + S.E.M. of the number of animals shown in 
parentheses.
Students t - te s t *  P < 0.05, * *  P < 0.01, N.S. not s ign ificant.
rate of incorporation into the fraction precipitated by CPC was very 
much greater than that of the acid precipitation by several orders 
of magnitude.
Effect of Carbenoxolone on the Incorporation of Radio-labelled Precursors 
into an Acid-Precipitable Fraction of Ferret Gastric Discs
Ferrets were dosed with carbenoxolone (25 mg/kg/day) in th e ir  
drinking water for seven days. Control animals received water only.
After seven days the animals were sacrificed and the incorporation 
assays carried out. The effects of carbenoxolone on the uptake of 
sugar and amino acid precursors are shown in Tables 2.4 and 2.5 
respectively.
As with the ra t , carbenoxolone fa iled  to show any significant 
effect on the incorporation of amino acids in the fe rre t stomach.
Again, however, there was a trend towards an increased uptake, 
particu larly  of serine in this species. A significant increase was 
observed for a ll of the sugars investigated with the exception of 
galactose for which the incorporation rate remained unchanged. The 
largest increase occurred with N-acetylglucosamine the incorporation 
rate of which was increased by approximately 250% over the controls.
The Effect of Ethanol on the Incorporation of N-acetyl [  H]glucosamine 
into Rat Gastric Resections
Rats were k illed  one hour a fte r dosing with ethanol (1 ml, 35% 
v/v aqueous soln. 1.9 mg/kg) by intubation and the incorporation of 
N -acety l-[ Hjglucosamine (2.5 yCi) measured. Control rats received 
water (1 ml) only. A note was made of rats whose stomachs showed 
haemorrhagic areas. The results are shown in Table 2.6.
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Table 2.4 The Effects of Carbenoxolone in the Rate of Incorporation 
of Sugar Precursors into an Acid Precipitable Fraction of 
Ferret Gastric Discs
Precursor Incorporation rate 
mmol x 10- 12/mg glycoproTein/h
Control Carbenoxolone-treated
Change from 
control %
N-acetyl - [^H] 
glucosamine
[ H]glucosamine
[*4C]galactose
140 + 4 (3)
4 + 0.4 (3) 
3300 + 410 (3)
N-acetyl- [ *V ]
neuraminic acid 275 ^ 2 0  (3)
480 + 18 (6 )*  + 243%
7 + (0.9 (6 )*  + 75%
3400 + 670 (6 ) N.S.
370 + 30 (6 ) *  + 36%
[ H]fucose 1.7 + 0.03(6) 2.2 + 0 .04(6)* + 30%
Results are expressed as means + S*E.M. of the number of animals shown 
in parentheses.
Students ' t 1 test *  P < 0.05, N.S. not s ignificant.
Table 2.5 The Effects of Carbenoxolone on the Rate o f
Incorporation of Amino Acids into an Acid 
Precipitable Fraction of Ferret Gastric Discs
Precursor Incorporation rate Change from
mmol x 10“ lz/mg glycoprotein/h. control %
Control Carbenoxolone-treated
rl4 i[  Cjthreonine 560 + 54 (3) 600 + 22 (3) N.S. + 7%
[ H]serine 6 3 + 8  (3) 123 + 40 (3) N.S. + 95%
13H]pro!i ne 60 + 23 (3) 45 + 23 (3) N.S. - 25%
|3 {| asparagine 126 + 45 (3) 122 + 32 (3) N.S. -  3%
Results are expressed as means + S.E.M. for the number of 
observations shown in parentheses.
Students 1t 1 tes t. N.S. not significant
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Table 2.6 The Effect of Alcohol Pretreatment on the Incorporation     ---------------------------------------------------------------------------
of N-acetyl-[ Hlglucosamine into an Acid Precipitable
Fraction of Rat Gastric Discs
Incorporation Rate Presence of
mmol x 10~' /^mg glycoprotein Haemorrhajpc
Control animals Alcohol treated
1 143 2 +
2 164 10 +
3 277 45 +
4 89 6 +
5 85 51 -
6 276 58 -
Mean + S.E.M. 172 + 26 29 + 11
Students t - te s t p < 0.001.
Alcohol had a potent inhibitory effect on the uptake of the sugar 
into the glycoprotein fraction , the rate of incorporation of N-acetyl
o
[ H]glucosamine being reduced by 83% of the control rate. Also in four 
of the six rats treated with alcohol haemorrhagic areas could be seen 
in the stomach.
Incorporation of N-acetyl [ Hjglucosamine and [  S] Sodium Sulphate 
into an Acid Precipitable Fraction of Human Gastric Biopsy Samples
The incorporation of labelled precursors into glycoproteins of human 
biopsy samples was carried out by the methods outlined in the Materials 
and Methods section. Substrates used in these studies were N -acetyl[3H]
o r
glucosamine (1 yCi) and sodium [  s] sulphate (1 pCi). Biopsy samples 
were obtained from apparently normal stomachs, diseased stomachs and in 
a few cases from the stomachs of patients with gastric u lcer, before and 
a fte r  carbenoxolone treatment. The results of these studies are shown 
in Tables 2.7 -  2.11.
Table 2.7 shows that in the normal stomach the incorporation rate  
of N-acetylglucosamine varies from one anatomical section of the stomach 
to another. Thus the antral mucosa has a higher rate of uptake of the 
sugar than does the lesser and greater curves which have approximately 
equal rates of incorporation.
Markedly d ifferen t incorporation rates were seen in biopsy samples 
taken from diseased areas of the stomach [Table 2 .8 ( i )J. Thus the uptake 
of N-acetylglucosamine into lesser curve biopsies from stomachs bearing 
an ulcer in this area is significantly  reduced. A sim ilar trend was 
observed in biopsies from antral mucosa in the same stomachs. In this  
case however, the trend was not s ign ifican t. Incorporation into greater 
curve samples was not effected.
Table 2.7
•O
Incorporation o f N -acetyl-[. H]glucosamine into an Acid Precip itable
Fraction of Biopsy Samples from Apparently Normal Human Stomachs
Patient No. Incorporation Rate mmol x lQ-tymg glycoprotein/h
Pyloric Antrum Greater Curve Lesser Curve
1 211 171 173
2 226 169 136
3 304 225 160
4 227 154 190
5 117 81 58
6 300 172 237
7 315 123 118
8 284 269 238
9 192 94 184
10 175 122 131
11 214 126 167
12 253 81 81
13 207 137 150
14 278 210 231
15 289 229 219
16 220 109 113
17 238 135 142
18 229 114 121
19 269 153 148
20 199 140 132
21 152 93 101
22 273 172 167
23 236 151 121
24 220 122 127
Means + S.E.M 2 3 4 + 9 . 8  1 4 8 + 9 . 6  1 5 1 + 9 . 5
Studentsvt-te s t Pyloric antrum v Greater curve P < 0.01
Pyloric antrum v Lesser curve P < 0.01
Greater curve v Lesser curve Not s ign ificant
Table 2.8 Incorporation o f N -ac e ty l-[. H]glucosamine in to  Acid
Precipitable Fractions of Human Gastric Biopsy Samples
in Diseased States o f the Stomach
( i ) Ulcer on lesser curve
Patient (age) C linical condition Incorporation Rate 
— ---------------------------------------
mmol x 10 /mg glycoprotein/h. 
Antrum Lesser Curve Greater Curve
Male, 64 Ulcer on lesser curve 
near pylorus
66
Male, 73 
Female, 48
Ulcer on lesser curve
Ulcer on lesser curve 244
33
95 116
Female, 64 Ulcer on lesser curve 165 99 116
Female, 65 Ulcer on lesser curve 223 125 319
Female, 52 Ulcer on lesser curve 221 113 160
Male, 53 Ulcer on lesser curve 232 105 147
Male 54 Ulcer on lesser curve 193 87 122
Means + S.E.M. 213 + 13.0N*S* 90.2+10.1** 163+35N,S-
Normal means + S.E.M.(Table 2,7) 234 + 9.8 148 + 9.6 151+9.5
Students't-test Ulcerated lesser curve v normal** P < 0.01
N.S. not s ignificant.
Table 2.8 continued
( i i ) G astritic conditions
Patient (age) C linical Condition
Male, 72 Severe gastritis
Male, 56 Atrophic gastritis
Male, 48 G astritis , partia l 
gastrectomy
Female, 78 Senile g a stritis
Male, 18 Severe gastritis
Female, 82 Senile gastritis
Male, 38 Antral gastritis
Means + S.E.M.
Normal means + S.E.M. (Table 2.7) 
Students%t-te s t G astritic  antrum v
Incorporation Rate 
mmol x 10" /mg glycoprotein/h 
Antrum Lesser Curve Greater Curve
142 202 142
112
, 205 249
126 109 152
157 183 94
139 161 104
118 153 167
136 + 6.7** 154 + 15.5NS 153 + 27.6NS 
234 + 9.8 148 + 9.6 151 + 9.5
normal**P < 0,01 N.S. not s ign ifican t.
Table 2.8 continued
( i i i )  Other conditions
Patient (age) C linical Condition Incorporation Rate  ---------------
mmol x 10 /mg glycoprotein/h 
Antrum Lesser Curve Greater Curve
Female, 85 Bleeding pre-pyloric ulcer 271 189 89
Female, 35 Multiple aphthous ulcers above
pylorus 89
Female, 88 Ulcer on antrum 127
129
164
126
154
Male, 67 Carcinoma on lesser curve 208 95 175
Male, 57 Carcinoma on lesser curve 92
(60 near cancer)
Male, ,64 Carcinoma on greater curve 203 147 102
Normal means + S.E.M. (Table 2.7) 234 + 9.8 148 + 9.6 151 + 9.5
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Sim ilarly a reduction in the uptake of hexosamine into glyco­
proteins from antral mucosal samples was observed in patients 
suffering from gastri tic conditions while lesser and greater curve samples 
from the same patients were approximately normal [Table 2.8 ( i i )]-
In other pathological conditions of the stomach the same 
pattern of decreased incorporation of N-acetylglucosamine was observed 
in the diseased portion of the stomach. The patient with multiple  
aphthous ulcers above the pylorus had a low rate of uptake into the 
antral mucosa and the two patients with carcinoma of the lesser curve 
had reduced levels of uptake into biopsy samples from this area [Table 
2.8 ( i i i ) ] .
Carbenoxolone treatment was shown to reverse the trend of diminished 
incorporation associated with gastric ulceration (Table 2 .9 ). In a ll 
cases carbenoxolone treatment resulted in healing the ulcer and an 
elevation in the uptake of N-acetylglucosamine. This e ffect was confirmed 
in the cases where biopsy samples were obtained on diagnosis of the ulcer 
and a fte r  treatment with the drug (Table 2 .10).
The experiments on the incorporation of sodium sulphate into the acid 
precipitable fraction of human gastric biopsy samples showed that in a ll  
five  subjects uptake of sulphate into the precipitated fraction did occur 
(Table 2 .11). An elevation in the rate of uptake was seen in the lesser 
curve of a patient with an ulcerated lesser curve and in a cancerous 
greater curve sample but the significance of these results could not 
be tested because of the small number of patients studied.
2.4 DISCUSSION
Using the techniques of Shillingford (1975) i t  has been demonstrated 
that glycoprotein synthesis can be studied in discs of gastric tissue 
over incubation periods of at least four hours. The in it ia l  lag phase 
observed in these preliminary experiments possibly represents the time 
required for diffusion and activation of N-acetylglucosamine prior to 
its  incorporation into high molecular weight molecules.
I t  is worth noting that cycloheximide at a concentration o f  lCf^M 
which has been shown to completely in h ib it protein synthesis in the gut 
(Lukie and Forstner, 1972) also inhibits the incorporation of N-acetyl­
glucosamine, confirming the glycoprotein synthesising a b il ity  of the 
tissue preparation used in these experiments. This inh ib ition , however 
is not complete, the incorporation of hexosamine into cycloheximide 
treated discs being approximately 60% of the control value a fte r four 
hours incubation. This continued incorporation in the absence o f 
protein synthesis may represent the addition of sugar units to incomplete 
oligosaccharide chains during in trace llu la r transport and secretion. 
Salivary and ovarian cyst mucus apparently possess a significant number 
of incomplete side chains (Carlson 1966; Lloyd et aj[, 1968), and s im ila rly , 
incomplete side chains in stored gastric mucus could provide a large 
reservoir of endogenous acceptor for N-acetylglucosamine incorporation.
Subsequent experiments showed the incorporation assay to be a useful 
tool for the j_n v itro  measurement of the in vivo effects of drugs on 
glycoprotein synthesis. A sim ilar increase in the rate of incorporation
to that seen in experiments in which N-acetyl-pH]glucosamine was 
administered in vivo a fte r carbenoxlone treatment (Shillingford, 1975)
was observed using the in v itro  incorporation system. The in v itro  
assay, however, has the advantage of being more economical in the 
use of radiolabelled substrates and does not suffer from the 
disadvantage of distribution of the labelled compound to other tissues 
and subsequent contamination of the isolated gastric fractions with 
radiolabelled secretory products from these tissues e.g. salivary  
mucus and blood.
The stimulation by carbenoxolone of the incorporation of N-acetyl- 
glucosamine into rat and N-acetylglucosamine, glucosamine, N-acetyl-  
neuraminic acid and fucose into fe rre t gastric glycoproteins is in 
agreement with the work of other authors who found elevated levels of 
hexosamines (Shillingford et al_, 1973) and N-acetyl neuraminic acid 
(Gheorghiu et al_, 1972; Shillingford et aT_, 1973) in ra t gastric glyco­
proteins by chemical analysis a fte r carbenoxolone treatment.
The increased incorporation of sugars without a concomittant 
increase in the incorporation rate of amino acids indicates that the 
primary effect of carbenoxolone is to modify the carbohydrate side chain 
of the glycoprotein rather than cause an overall increase in the rate of 
glycoprotein synthesis or an alteration in the polypeptide backbone. 
However, the non-significant trend towards increased incorporation of 
serine and threonine suggests that an e ffect on protein synthesis 
cannot be ruled out completely.
The absence of increased incorporation of galactose into fe rre t  
gastric mucosal glycoproteins a fte r carbenoxolone treatment is d if f ic u lt  
to interpret in view of the increase seen with the other sugars, 
particularly i f ,  as the case in human gastric mucin, a disaccharide 
of N-acetylglucosamine and galactose constitutes a major portion of the
carbohydrate side chain (Oates et al_, 1974).
However, carbenoxolone has also been shown to have anomolous effects 
on galactose incorporation in the rat stomach. Shillingford et al_ (1973) 
found that pretreatment with the drug caused a decrease in the incorporation 
rate of galactose. I t  is possible that carbenoxolone as well as producing 
a more heavily glycosylated glycoprotein, as evidenced by the increased 
uptake of N-acetylglucosamine, fucose and N-acetylneuraminic acid, may 
also result in the production of a modified carbohydrate side chain 
characterised by a low galactose content.
A possible explanation of the action of carbenoxolone on the 
incorporation of the component sugars of the carbohydrate chain is 
that the ac tiv ity  or specific ity  of glycosyltransferases which assemble 
the oligosaccharide is altered. In particular an action on the transferases 
responsible for the addition of the f i r s t  few sugars would e ffec t the specific ity  
and ac tiv ity  of a ll subsequent glycosyltransferases and hence the structure 
of the oligosaccharide produced.
I t  has previously been shown that factors associated with mucosal 
damage such as restra in t (Lambert et a l , 1969) and aspirin administration 
(Rainsford, 1975) led to a decrease in the sulphate content in ra t gastric  
mucus. Moreover, this decrease has been shown to be the result o f a 
decrease in synthesis rather than an increase in the catabolism of 
sulphated glycoproteins (Dziewwiatkowski, 1964). Carbenoxolone was shown 
to have the opposite e ffect causing an increase in the extent o f sulphation 
of the glycoproteins. This e ffec t, at least in part, may explain the a n ti­
peptic action of carbenoxolone (Birnbaum and Karmeli, 1975) since sulphated 
poly-anions have been shown to in h ib it pepsin (Martin et a][, 1968).
The drug-induced increase in the incorporation of sulphate was apparent 
afte r both acid and cetylpyridinium chloride precipitation. The level of
incorporation into these materials precipitated by the two methods was 
however markedly d iffe ren t, that in the cetylpyridinium chloride 
precipitate being several orders of magnitude greater than the acid 
precipitate. The reason for this difference is in the nature of the 
fraction isolated. Acid, being a non-specific precipitating agent, 
results in the isolation of a fraction containing macromolecules from 
non-mucosal and mucosal cells containing neutral glycoproteins as well 
as sulphated glycoproteins. The weight of the precipitate was 50-60 mg. 
Sulphate incorporation when related to this weight is low. In contrast 
cetylpyridinium chloride is re la tive ly  specific, resulting in the 
precipitation of acid macromolecules such as nucleic acids and sulphated 
glycoproteins (weight of precipitate 3-5 mg), due to the formation of 
quaternary ammonium complexes (Scott, 1960). Hence considerably higher 
incorporation rates are seen using this method.
Although conclusive evidence for the involvement of alcohol in 
human gastric ulceration is lacking (Cooke, 1976) a number of authors 
have shown i t  to cause mucosal damage in animals (Williams, 1969;
Eastwood and Kirchner, 1974). These reports are supported by the 
dramatic decrease in the incorporation of N-acetylglucosamine and the 
development of gastric erosions a fter ethanol administration.
Davenport (1967) found that gastric mucosal damage, measured by 
a drop in the transmucosa1 potential due to back diffusion of hydrogen 
ions occurred a fte r ethanol administration. Although this back diffusion  
may stem from a general cytotoxic effect on the mucosal cells i t  may also 
re fle c t a direct effect of alcohol on mucus synthesis causing a weakened 
mucosal barrier.
Mucus synthesis, measured by the rate of incorporation of N-acetyl-  
glucosamine was shown to vary between the anatomical divisions o f the human
stomach. This reflects the distribution of mucus secreting cells  
throughout the stomach, the antrum having the highest concentration.
The results do, however, support the protective role of mucus in the 
stomach since the antrum is a low risk area with regard to ulceration, 
whereas the lesser curve may be regarded as a high risk area (Johnson, 
1965).
Disease states of the stomach such as gastric ulcer, g as tritis  
and carcinoma have been shown to be associated with a decrease in the 
incorporation of N-acetylglucosamine, indicating a malfunction in 
mucous glycoprotein synthesis. This conclusion is supported by the 
findings of Dornschke et al (1972) that N-acetylneuraminic acid levels 
were depleted in mucus from gastric ulcer patients.
The production of sulphated glycoproteins was also shown to be 
altered in disease states of the stomach. In contrast to the decreased 
sulphation seen in animals (Lambert and Andre, 1969) human gastric 
lesions are associated with increased sulphation of glycoproteins.
This finding is in agreement with the postulate of Lambert and Andre 
(1972) that human gastric disease is associated with an increased 
secretion of sulphated mucin.
The same authors suggest that normal human gastric mucosa does 
not secrete appreciable amounts of sulphated mucin and that the presence 
of sulphated glycoproteins in gastric aspirates (Schrager and Oates, 1971) 
is due to contamination by salivary and bronchial secretions. The 
occurrence of sulphate incorporation into endoscopically diagnosed normal 
mucosae does not support this hypothesis. Further indications o f the 
a b ility  of the human gastric mucosa to produce sulphated glycoproteins 
is provided by the demonstration of the ir presence in extracts from 
surgically removed gastric tissue (Schrager and Oates, 1974).
The trend towards decreased incorporation of N-acetylglucosamine 
in biopsy samples from gastritic  and gastric ulcer patients could be 
reversed by carbenoxolone therapy. The results suggest that carbenoxolone 
may have the same effect in man as in rats and fe rre ts , perhaps resulting  
in the production of a mucus glycoprotein with an altered carbohydrate 
side chain and an increased carbohydrate to protein ra tio , having 
greater resistance to proteolytic attack (Menguy and Desbaillets, 1968) 
and thus being able to afford protection to the mucosa.
S im ilarly, i t  may be argued that gastric ulcer is associated 
with the production of an under-glycosylated mucin or with a modified 
oligosaccharide chain structure within the mucin. Evidence exists that 
disease states of the stomach, such as carcinoma, may be associated with 
changes in the quantitative relationships of the sqgars comprising the 
carbohydrate portion of the mucin.(Schrager and Oates, 1973). Such a 
modified glycoprotein may not have the protective a b ility  of normal mucus 
glycoprotein. A depletion in N-acetylneuraminic acid, suggested as being 
essential for the protective viscous properties of mucus (Gottschalk,
1960) has been shown in gastric ulcer patients (Domschke, 1972).
I t  may be postulated that the primary cause of gastric ulceration 
is a derangement in glycoprotein synthesis leading to impaired mucosal 
defence. Such a derangement could occur at the polysomal level as is  
believed to be the case with the carcinogenic lesion (Webb et al_, 1965) 
which appears to be related to ulceration in the stomach with regard to 
incorporation of hexosamines. I t  is worth noting that gastric ulcers, 
particularly on the greater curve have a tendency to become malignant 
and gastric carcinomas frequently ulcerate (Montgomery and Richardson, 
1975).
CHAPTER THREE
THE EFFECTS OF DRUGS ON GLYCOPROTEIN SYNTHESIS 
IN RAT GASTRIC MUCOSAL SCRAPINGS
f
3 .1 . INTRODUCTION
The work of the previous chapter showed that glycoprotein synthesis 
and the effects of ulcerogenic and anti ulcerogenic drugs upon this synthesi: 
could be studied in discs of tissue taken from the stomachs of animals.
This chapter contains details of an alternative system for studying 
glycoprotein synthesis in the stomach. The technique is based on a further 
modification of the method of Lukie and Forstner (1972) and measures the 
incorporation of radiolabelled precursors into an acid precipitable  
fraction of rat gastric mucosal scrapings.
I t  was fe l t  that the use of mucosal scrapings would give a more 
accurate reflection of glycoprotein synthesis since the fraction isolated 
a fte r incubation would contain macromolecules of mucosal origin without
i
contamination by components of the muscular and connective tissue layers 
of the stomach. Exclusion of these contaminants should lead to increased 
incorporation rates with the use of homogenised mucosal scrapings.
Using this technique the effect of a number of anti-ulcerogenic and 
ulcerogenic drugs on glycoprotein synthesis was studied both when added 
to an isolated mucosal cell homogenate and when administered to animals 
before determination of the in v itro  incorporation of hexosamine.
The anti-ulcerogenic drugs used in these studies were carbenoxolone 
which has been discussed in the previous chapter, a carbenoxolone analogue 
BX363A, the E type prostaglandins and th e ir  synthetic derivatives (see 
Figs. 1.4 and 3.1) and 1-glutamine. The ulcerogenic drugs studied were 
indomethacin, ethanol and pen ic illin  G.
A great number of reports have appeared on the anti-u lcer e ffec t of 
the prostaglandins and prostaglandin analogues. Most of the work in this
Figure 3.1 Structures of BX363A and Prostaglandin Analogues
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f ie ld , however, has been concentrated on trying to prove a relationship
between the anti-u lcer effect of these compounds and th e ir  a b ility  to
in h ib it gastric acid secretion (Bass, 1974), possibly via cyclic AMP
(Bieck et aU 1973). Few authors have considered the effect of prostaglandins
on mucus synthesis and secretion in relation to ulcer healing. Fung et al
(1974a) have demonstrated endoscopically and histologically that the
prostaglandin analogue 15-R-15 methyl PGE2 methyl ester, which has been
shown to be beneficial in the treatment of gastric ulcerationfFung et al,1974b), has
a powerful stimulatory e ffec t on the production of gastric mucus in ulcer
patients. Thus i t  is possible that the other prostaglandins which have
been shown to be anti ulcerogenic in animals, PGE^  (Lippmann, 1974), PGE-j
(Robert et a l , 1968), compound AY22469 (Lippmann, 1974) and 16,16 dimethyl
PGE2 (Robert et al_, 1976) may also have an effect on mucus synthesis and
exert th e ir beneficial action through such an e ffec t.
S im ilarly, the amino acid 1-glutamine has been shown to be effective  
in suppressing gastric ulceration induced by stress in rats (Takagi and 
Okabe, 1968) and aspirin (Okabe et au[, 1974; Tanaka et al_, 1974). These 
authors have related this beneficial e ffect to the a b ility  of 1-glutamine 
to in h ib it the back diffusion of gastric HC1 although they do not postulate 
a mechanism for this inh ib ition . Again an effect on mucus production has 
not been considered.
Despite the lack of a positive correlation between indomethacin use 
and chronic gastric ulceration in humans (Cooke, 1976) the drug has been 
shown to be ulcerogenic in animals (N icoloff, 1968) and to cause acute 
gastric mucosal lesions in patients with rheumatoid a rth rit is  (Mengqy, 1969).
In animals the development of the lesion has been shown to be associated 
with a decrease in the concentration of protein bound carbohydrates, 
particularly hexosamines and s ia lic  acids, of gastric mucus. Thus, the
ulcerogenic effect of the drug may in part be mediated through an 
effect on glycoprotein synthesis.
S im ilarly, ethanol (Williams, 1969) and pen ic illin  G (Lyle, 1974) 
have been shown to be associated with mucosal lesions in animals and 
humans. In the case of p en ic illin  G the active mucosal damaging agent 
is thought to be penicillamine, a product of pen ic illin  G metabolism.
3.2 MATERIALS AND METHODS
Chemicals
Carbenoxolone sodium and compound BX363A were g ifts  from Biorex 
Laboratories L td ., London. Prostaglandins E^, E2 , 15-R-15 methyl 
prostaglandin E2 methyl ester and 16,16 dimethyl prostaglandin E2 
were g ifts  from Dr. J.E. Pike, The Upjohn Company, Kalamazoo,
Michigan. The prostaglandin analogue AY 22469 was donated by Dr.
W. Lippman, Ayerst Laboratories, Quebec. Radiochemicals (Table 2.2) 
were purchased from The Radiochemical Centre, Amersham. Sephadex 
G-200 and ConA-Sepharose were obtained from Pharmacia (G.B.) L td ., 
London.
Animals
The animals used in this series of experiments were female Wistar 
albino rats (200-250g).
o
Incorporation of N-acetyl-| Hlglucosamine into an Acid Precipitable  
Fraction of Rat Gastric Mucosal Scrapings
Rats were k illed  by cervial dislocation and the stomachs isolated  
and washed as previously described (Chapter 2 .2 ). The stomachs were 
stretched out on a glass plate and the layer of mucus lin ing the 
glandular area of the stomach removed by lig h tly  scraping with a glass 
microscope slide. The mucosa was then separated from the muscular 
layer, again by scraping with a glass s lide. The mucosal scrapings 
from each stomach were homogenised in 15 ml incubation medium using a 
Potter-ElvejhEm homogeniser. The medium.was that of Lukie and Forstner 
(1972) used previously (NaCl, 119 mM; KCL, 5.6 mM; CaCl2 3.0 mM;
KH2P04 9 ^  NaHCOg, 29.3 mM; L-glutamine, 80 mM).
Aliquots (5 ml) of homogenised mucosal scrapings were incubated 
in a Mickle shaking incubator at 37°C and 100 oscillations/m in.
Incubation periods were for 4 hours, except where specified, and 
were started(after a preincubation period of 10 min) by the addition 
of N-acetyl-[^H]glucosamine (2.5pCi) in a small volume of 0.9% NaCl 
(50yl) . Throughout the incubation flasks were flushed with 02-C02 
(95%-5% v/v ) every 10 min. Incorporation was terminated by the 
addition of 5 ml trichloroacetic acid:tungstophosphoric acid ( 20% w/v:
2% w/v ) .
The fraction precipitated overnight was collected by centrifugation  
at 2,000 g for 10 min in an MSE Mistral centrifuge. The material was 
washed twice with d is tille d  water, extracted twice for lip ids with 
chloroform-methanol ( 1: 1) ,  a ir  dried and weighed.
Studies on the re lative rates of incorporation of other sugars were
•3performed by adding amounts equivalent to 2.5yCi of N-acetyl [  H]glucosamine 
(6.25 x l0 ”^°mol). In further studies on the re la tive  incorporation rates 
of d ifferen t sugars the assays were carried out using 50x10"5M concentrations 
of the sugar being investigated.
Determination of Radioactivity
Radioactivity incorporated into the precipitated fraction was 
determined by the method used in the previous chapter. In this case 
solubilisation was with perchloric acid (0.2  ml, 60% w/v ) and hydrogen 
peroxide (0.4 ml, 100 vols). S c in tilla tio n  counting was carried out 
in a Packard Tri-Carb Spectrometer (Model 3320) using an external 
standard channels ratio  method for determination of counting effic iencies  
or in an LKB Wallac Ultrabeta 2002 s c in tilla tio n  counter, programmed for  
d.p.m. calculations based on internal standard channels ratio  efficiency  
determinations.
Examination o f Drug Effects In Vivo and In Vitro
To examine the in v itro  effects of drugs on the incorporation 
assay they were added in a small volume of vehicle to the flasks 
containing the mucosal preparation prior to incubation. Control 
flasks received vehicle only. In these experiments aliquots from a 
bulked mucosal homogenate, prepared from a number of stomachs, were 
used.
The in vivo effects of drugs were determined by pretreatment 
of the animals prior to k illin g . Control animals were treated 
identically but with the omission of the drug. Details of the drugs 
and dosing regimes used are given in the Experimental and Results 
section.
Analysis of Radioactively Labelled Rat Gastric Mucosal Glycoprotein 
by Concanavalin A-Sepharose A ffin ity  and Sephadex G-200 Gel Chromatography.
Column preparation
Sephadex G-200 (superfine) was equilibrated in sodium bicarbonate 
(0.1M) for 3 days at room temperature and packed into a chromatography 
column (40 x 3 cm) using the technique outlined by the manufacturers 
(Sephadex, Gel F iltra tio n  in Theory and Practice). The void volume was 
determined using Blue Dextran 2000 and the column calibrated for molecular 
weight determinations by measuring the volume of elution of cytochrome 
C (M.W. 13,000), ovalbumin (M.W. 45,000), bovine serum albumin (M.W. 67,000) 
and yeast alcohol dehydrogenase (M.W. 150,000). A calibration curve was 
plotted using the relationship:
ve/vo = k log M
in which, ve = volume of elution, vo = void volume, M = molecular weight 
and k is a constant.
Concanavalin A-Sepharose was equilibrated with sodium bicarbonate 
(0.1M) for 3 days at room temperature and packed into a chromatography 
column (20 x 0.9 cm). On settling the column was washed with further 
additions of sodium bicarbonate.
Sample preparation
Incorporation of N-acetyl |*^H]glucosamine into a bulked mucosal 
homogenate from 6 rats was carried out as previously described.
Incubations were terminated by the addition of ice cold d is tille d  
water and the combined contents of the flasks exhaustively dialysed 
against d is tille d  water (5 changes) at 4°C for 24 hr to remove free 
N-acetylglucosamine and radiolabelled low molecular weight molecules.
After centrifugation to remove water insoluble materials the supernatant 
of the dialysate, containing water soluble glycoproteins, was freeze- 
dried. The lyophilized material was redissolved in 10 ml NaHCOg (0 .1M) 
and applied to the Concanavalin A-Sepharose column.
Chromatographic separation
Material was eluted from the Concanavalin A-Sepharose column using 
the following eluants:
1) sodium bicarbonate (0.1M)
2) sodium chloride (1M)
3) d is tille d  water
4) methyl-a-D-glucopyranoside (50 mg/ml).
Methyl-a-D-glucopyranoside which has a high a f f in ity  for Concanavalin 
A was used to displace glycoproteins from the column. Fractions (3 ml) 
eluted with this material were analysed for rad ioactiv ity . Those containing 
radiolabelled material were combined (fin a l volume, 36 ml) dialysed against 
d is tille d  water to remove the a-methylglucose and lyophilised.
The dried material was redissolved in 5 ml NaHCOg (0.1M) and 
applied to the Sephadex G-200 column. The column was eluted with 
NaHCOg, flow rate 0.10 ml/h,operating pressure 15 cm HgO, and 3 ml 
fractions collected. Aliquots (0.5 ml) of each fraction were 
analysed for radioactivity and the protein content of each fraction  
measured by the method of Lowry et al_ (1951).
An analysis of the glycoprotein from rats pretreated with 
carbenoxolone (25 mg/kg/day, fo r 7 days) was carried out using the 
same procedures.
Hydrolysis of Radioactively Labelled Rat Gastric Mucosal Glycoprotein.
The fractions from the Sephadex column described above which were
i
shown to contain radiolabelled glycoprotein were combined and freeze 
dried. The material was used in the following hydrolysis studies.
S ia lic  acids
S ialic  acid residues were cleaved from the glycoprotein (10 mg 
freeze dried material) by hydrolysis under nitrogen in a sealed 
container for 40 min with 0.1 N HgSO^  (2 ml) a t 80°C (Gottschalk,
1960). After cooling, the hydrolysis mixture was made neutral by 
addition of saturated Ba(0H) 2 and mixed with ethanol (3 v o l). After 
Ih a t 4°C, the precipitated mucin and BaSO^  were deposited by 
centrifugation and the supernatant was shaken with Dowex 50 (H+ form) 
resin (1 vol resin:5 vol of supernatant). The cation-free solution 
was decanted and the resin was washed once with water (5 v o l). The 
combined supernatant and washings were freeze dried and the residue 
containing s ia lic  acid dissolved in water (200p l) and examined by 
thin layer chromatography.
Neutral sugars
Neutral sugars were released from the glycoprotein material (10 mg) 
by hydrolysis under nitrogen in 0.5N (2 ml) for 3h at 105°C (Mah,
1961). The resulting hydrolysate was passed down a column (1 cm x 10 cm) 
of Amberlite Monobed 3 to remove acid residues. The column eluate 
(about 50 ml) was freeze dried and redissolved in water (200yl) and 
examined by thin layer chromatography.
Amino sugars
The glycoprotein fraction (10 mg) was hydrolysed under nitrogen 
in 2 NHC1 (2 ml) a t 105°C for 16h.(B lix, 1948). The resulting humin 
was centrifuged and the hydrolysate was evaporated to dryness in 
vacuo at room temperature over P2O5 and NaOH. The dried residue was 
dissolved in water (200pl) and examined by thin layer chromatography.
Thin Layer Chromatographic separations
The products of the preceding hydrolyses were examined by thin  
layer chromatography. The adsorbant and solvent systems used are 
shown in Table 3 .1 .Duplicate samples (50ul hydrolysate) were spotted 
on the chromatography plate. Relevant standards of cold sugars 
(0.5 mg) were run in p a ra lle l. After running sugars were detected on 
the plates with alkaline s ilver n itra te . Coincidence of rad ioactiv ity  
with the sugar spots was determined by scanning the T.L.C. plates using 
a Berthold LB 27723 radioplate scanner.
1
Table 3. 1 T.L.C. systems used in analysis of hydrolysis 
products of rat gastric mucosal glycoprotein
Sugar
Neutral sugars
Amino sugars
S ia lic  acids
Adsorbant
S ilica  gel G +
0.02M sodium acetate
Solvent System
Acetone .-water I
(9:1)
Cellulose
Cellulose
Pyridine: 
ethylacetate: 
acetic acid: 
water 
(5 :1:3 :1)
Pyridine: 
ethylacetate: 
acetic acid: 
water 
(5 :1 :3 :1)
I I
I I
S ilica gel N-propanol: I I I
ethylacetate: 
water:15 M NH~
(5 :1 :3:1) J
Cellulose Ethanol: IV
water:
ammonia soln.
(sp .g r.0 .88)
(,80:20:1)
J
3.2 EXPERIMENTAL AND RESULTS
.O
The uptake of N-acetyl- [  H]glucosamine into the acid precipitable  
glycoprotein fraction of rat gastric mucosal scrapings was shown to be 
approximately linear for at least four hours (Fig. 3 .2 ). This 
incorporation was shown to be dependent on the presence of oxygen 
(Fig. 3.2) and absent when the mucosal preparation was denatured by 
heating (Fig. 3 .3 ).
The assay was shown to have sim ilar characteristics to that used in 
Chapter 2 in that the level of incorporation could be reduced to approximately
60% of the control value by the presence’ of the protein synthesis
-4inhib itor cycloheximide a t a concentration of 10 M (Fig. 3 .4 ) . Also 
the optimal concentration for the substrate in the modified Krebs medium 
of 8mM glutamine (Fig. 3.5) is sim ilar to that required for incorporation 
into gastric slices (S hillingford, 1975).
Antibiotics were not added routinely to the incubation medium to  
in h ib it the effects of contaminating bacteria since the an tib io tic  
cycloheximide at a concentration of 1.5 yg/ml showed no effec t on the 
uptake of hexosamine over the four hour period (Fig. 3 .6 ). In an attempt 
to determine whether the stomach microflora were capable of incorporating 
significant amounts of N-acetylglucosamine into acid precipitable glyco­
proteins the washed stomachs, prior to incubation, were agitated with 
medium for 5 min. to release adherent microorganisms and the medium 
alone incubated with N-acetyl- [  H]glucosamine for 4 hours. Total 
incorporation of radioactivity into acid precipitable material was less 
than 1% of the incorporation occurring with mucosal scrapings.
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Fig. 3.2 E ffect of oxygen on the incorporation of N -a c e ty l-f3H1-glucosanine
into gastric  mucosal scrapings
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Results are plotted as means ± SEM of three observations. Open 
triangles represent unoxygenated mucosa, closed triangles oxygenated 
mucosal scrapings.
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Incubation Time (h)
Results are plotted as means + SEM of four observations. Closed 
triangles represent control incubation, open triangles represent 
incubation with denatured mucosal scrapings.
3.4 Effect of IQ^M cycloheximide on the incorporation of N-acetyl- 
rj H l-rglucosamine into rat gastric mucosal scrapings
80 •
1 2 3 4
Incubation Time (h)
Results are plotted as means ± SEM of three observations. Closed 
triangles represent control incubation, open triangles represent 
incubation in the presence of cycloheximide (10_lfM).
In
co
rp
or
at
io
n 
Ra
te
 
n 
mo
l 
x 
IC
fV
m
g 
gl
yc
op
ro
te
in
70
60
50
40
30
20
10
Glutamine Cone. (mM)
Fig. 3.5 The effect of glutamine concentration on the incorporation of 
N-acetyl-r^Hl-glucosamine into glycoproteins from gastric  
mucosal scrapings
Results are plotted as means ± SEM of four observations.
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Results are plotted as means ± SEM of three observations. 
Closed triangles represent control incorporation. Open 
triangles incorporation in the presence of cycloheximide.
The In V itro  Effects of Compounds on the Incorporation of N-acetyl-[^H]
glucosamine
The in v itro  effects of carbenoxolone, indomethacin, ethanol, and 
p en ic illin  G on the uptake of hexosamine were determined by the addition 
of the compounds in small volumes (50yl, except for ethanol, 500yl) of 
aqueous solutions or suspensions (indomethacin) to the mucosal 
preparations prior to the addition of N -acety l-[ Hjglucosamine. The 
final concentration of the drugs and the results of the incorporation 
assays are shown on Table 3 .2 .
A series of natural, synthetic and semi-synthetic prostaglandins,
consisting of PGE-j, PGE2, 15-R-15 methyl PGE2 methyl ester, 16,16
dimethyl PGE2 and compound AY22469, and cyclic AMP were also tested
t-3 tfor the ir in v itro  effects on the incorporation of N -acety l-[ H j-
glucosamine. Cyclic AMP was added to the mucosal preparation as an
-12aqueous solution (50yl) to give a fina l concentration range of 10 -
-410 M. The prostaglandins were added in 50yl of 3% ethanol to give a 
final concentration range of 6-180yM. Control preparations were treated  
with the respective solvents. The results of the incorporation studies 
are shown in Table 3.3 .
Of the compounds added to the incubation medium only the prostaglandin 
analogue AY22469 appeared to increase the incorporation o f the amino sugar. 
This increase however was s light (approx. 12%) and did not appear to be 
concentration-dependent over the range of concentrations used. The other 
prostaglandins studied in v itro  e ither had no effect on the incorporation 
(15-R-15 methyl PGE2 methyl ester and 16,16 dimethyl PGE2) or showed a
Table 3.2 Effects of ethanol, carbenoxolone, indomethacin and penic i l l in  
G in vitro  on~the rate o fin co rp o ra tio n o f N -acety l-f3K l- 
glucosamine into the acid-precipitable fraction of rat gastric  
mucosal scrapings"
Compound Final concn. in Incorporation rate Change from
added incubation medium n mol x 10~Vmg glycoprotein control T ~
Control Experimental
Carbenoxolone . IOjjM 69.6U6.6 (4) 65.11, 67.86 0
lOOyM 69.6H 6.6 (4) 62 .28 ,65 .64 0
ImM 69.6U6.6 (4) 50.76, 44.18 -32%
Indomethacin lOyM 69.45±2.45(4) 69.0 , 66.86 0
lOOpM 69.45±2.45(4) 66.34, 68.79 0
ImM 69.45±2. 45(4) 52.87, 49.97 -24%
Ethanol 10% v/v 54.7 ±3.8 (6 ) 11.5 ± 0.75(6) -78%
P en ic illin  G 200 units/ml 93.5 ±7.73(3) 28.5 ± 0.23(3) -30%
Results are shown as means ± S.E.M. where the number of observations was 
greater than two (numbers in parentheses indicating number of observations)*
Students*t-test * * *  p < 0.001
-  95 -
Table 3.3 Effects o f PGE ,^ PGEp, 15-R-15 methyl PGE,, methyl ester
16,16 dimethyl PGE ,^ AY 22469 and cyclic AMP in v itro  
on the rate of Incorporation of N -acety l-[ H]glucosamine 
into the acid-precipitable fraction of ra t gastric  
mucosal scrapings
Compound Final concn in Incorporation Rate Change from
added incubation medium nmoi x 1 Q"Vmg glycoprotein control %
Control Experimental
PGE-j 6 - 180yM 47.79 + 1.76(4) 43.62 + 0.8 (8 ) -  9%
PGE2
15-R-15
PGE2
AY 22469
6 -  180yM 62.03 + 1.37(4) 54.19 + 1 .1  (8 ) -  11%
6 -  180yM 61.50 + 0.46(4) 60.21 + 0.74(8) -
6 -  180yM 63.48 + 1.08(4) 61.70 + 2.03(8) -
6 -  180yM 54.85 + 1.27(4) 6 1 .5 3 + 0 .8 6 (8 ) + 12%
10”12-10”4M 59.39 + 2.94(3) 60.47 + 1.24(9) -
Prostaglandins were added in 50 yl aqueous ethanol to give fina l
concentrations of 6 , 12, 30, 60, 90, 120, 150 and 180yM.
Cyclic AMP was added in 50yl aqueous solution to give fina l
concentrations of 10 , 10" . . . . . . lO'^M.
Results are shown as means + S.E.M. where the number of observations 
was greater than two (numbers in parentheses indicating the number 
of observations).
slight inhibition (PGE1 and PGE2) of approximately 10%. Again 
these changes did not show a concentration-dependency.
Cyclic AMP was shown to have no effect in v itro  on the uptake of 
hexosamine over the concentration range used.
A ll of the other compounds examined in v itro  resulted in decreased 
incorporation of N-acetylglucosamine. Ethanol was by fa r  the most potent 
inh ib itor and at the concentration used caused a 78% decrease in the rate 
of incorporation. Carbenoxolone and indomethacin appeared to have a 
concentration dependent e ffec t, ImM concentrations showing inhibitions of 
32% and 24% respectively. S im ilarly pen ic illin  G caused an inhib ition of 
30% at a concentration of 200 units/ml.
The Effects of Pretreatment of Rats with Carbenoxolone on the Incorporation
. !
of N-acetylglucosamine, Glucosamine, Glucose, Galactose and Galactosamine 
into an Acid Precipi table Fraction of Rat Gastric Mucosa
Rats treated with carbenoxolone (25mg/kg/day for seven days) were 
sacrificed and mucosal preparations made. The incorporation of N-acetyl- 
[ 3H]-glucosamine, [3H]-glucosamine, [ 3H]-glucose, [3H]-galactose and [ ll*C]- 
galactosamine was carried out with and without the addition of unlabelled 
sugars(5 x l ( f 5M concentrations of each respective sugar). The results are 
shown in Table 3.4 and Table 3.5.
The experiments in which labelled sugar only was added to the 
incorporation assay (Table 3.4) showed that the sugars were not equally 
incorporated into the precipi table glycoprotein fraction . N-acetylglucos­
amine was by fa r  the best substrate for the assay, followed, in order of 
descending incorporation rate, by glucosamine, galactose, glucose and 
galactosamine.
Table 3 .4  Effects of carbenoxolone on the incorporation of
-10 36.25 x 10 M concentrations of N-acetyl[ H]glucosamine,
3 "3 3f H]glucosamine, | H]g1ucose, f H]galactose and
.*14I Cjgalactosamine into an acid precipi table fraction  
of ra t gastric mucosal scrapings
Sugar I ncorporation rate 
nmol x 10-5/mg glycoprofei n/4h
Change from 
control (Tf
Control Carbenoxolone
treated
glucosamine 416 + 83.8 (4) 754 + 39.5 (4) + 81,3%
o
[ H]glucosamine 153 + 7.5 (4) 302 + 19.1 (4) + 98.0%
[3H]glucose 1.98 + 0.33 (4) 3.92 + 0.15 (4) + 97.9%
[3H]galactose 3.7 + 0.19 (4) 2.4 + 0 . 2 9 ( 4 ) -  35.1%
f^C]galactosamine 1.92 + 0.26 (4) 3 . 5 3 + 0 . 5 0 ( 4 ) + 83.9%
* *
* *
Results are expressed as means + S.E.M. of the number of observations 
shown in parentheses.
Students't-test *  P < 0.05, * *  P < 0.01, * * *  P < 0.001.
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Table 3,5 Effect of carbenoxolone on the incorporation of
-55 x 10 M concentrations of N-acetylglucosamine, 
glucosamine, glucose, galactose and galactosamine 
into an acid precipi table fraction of ra t gastric  
mucosal scrapings
Sugar Incorporation rate Change from
nmol/mg glycoprotein/4h. control (%)
N-acetylglucosamine
Control
12.9 + 0.52(4)
Carbenoxolone
treated
29.1 + 1.72(4) + 125%
•kick
Glucosamine 11.7 + 0.24(4) 29.2 + 1.26(4) + 149%
kkk
Glucose 4.5 + 0.23(4) 3.95 + 0.07(4) - 12% N.S.
Galactose 6.8 + 0.53(4) 7.3 + 0.28 (4) + 7% N.S.
Galactosamine 3.2 + 0.56(4) 5.7 + 0.68 (4) +
COr^. *
Results are expressed as means + S.E.M. of the number of observations 
shown in parentheses.
Students'tAtest *  P < 0.05, * * *  P < 0.001, M.S. not s ignificant.
Carbenoxolone pretreatment caused a significant increase in the 
rate of uptake of N-acetylglucosamine, glucosamine, glucose and 
galactosamine. In contrast, however, the rate of incorporation of 
galactose was significantly  reduced (-35%) a fte r carbenoxolone 
treatment.
Substantially d ifferent results were produced when the same 
incorporation assays were carried out in the presence of 5 x ICf 5M 
concentrations of the sugars (Table 3 .5 ). Whereas N-acetylglucosamine 
and glucosamine were again incorporated at higher rates than the 
other sugars the uptake of glucosamine was equal to N-acetylglucosamine. 
The effect of carbenoxolone in producing a significant increase in 
the uptake of glucose and reduction in that of galactose was not 
apparent at this higher concentration of sugar.
The Effect of Pretreatment of Rats with Carbenoxolone, BX 363A, 
P enic illin  G, Ethanol and Indomethacin on the Incorporation of 
N-acetyl- f3Hl-glucosami ne
The in vivo effects of these drugs was determined by pretreatment 
of rats prior to sacrifice. The dosing regimes used are shown on 
Table 3.6 and the results of the incorporation assays in Table 3.7.
As in the previous studies carbenoxolone was shown to cause an 
increase in the rate of uptake of hexosamine into the precipi table 
glycoprotein fraction. Seven days dosing with carbenoxolone showed 
an increase of 51% and fourteen days dosing and increase of 215% in 
the rate of incorporation over controls. An increase of 35% was 
observed a fte r seven days dosing with BX 363A.
P enic illin  G, a fter seven days dosing, and ethanol one hour 
after a single dose, caused inhibitions in the rate of incorporation
Table 3,6 Dosing regimes used to determine the effects  of
carbenoxolone BX 363A, pen ic illin  6, ethanol and 
indomethacin on gastric glycoprotein synthesis
Compound Dose Level Route of Administration Dosing Period
Carbenoxolone 25 mg/kg/day Orally in drinking water 7-14 days
BX 363A 25 mg/kg/day Orally in drinking water 7 days
P en ic illin  G 0.15mg/kg/day Orally in drinking water 7 days
Ethanol 1.9mg/kg ,,
(1 ml 35I w/v )
Intubation single dose,sacrificed 
a fte r 1 hour
Indomethacin 10mg/kg (0.2ml 
3% aq. ethanol)
Intubation ii n  n  it it it
Prostaglandin
Ei 1.5mg/kg (0.2ml 3% aq. ethanol)
Intubation H  it it ii it ii
Prostaglandin
E2 1.5mg/kg(0.2ml 3% aq.ethanol)
Intubation ii ii ii ii ii ii
15-R-15 methyl 
PGE« methyl 
ester
1,5mg/kg(0.2ml 
3$ aq. ethanol)
Intubation ii ii ii ii it ii
16,16,dimethyl
pge2 1.5mg/kg(0.2ml 
3% aq.ethanol)
Intubation ii it ii ii . it ii
AY22469 1.5mg/kg(0.2ml 
3% aq.ethanol)
Intubation ii ii ii ii ii ii
Control animals received vehicle only delivered by the same route 
as the test solutions.
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Table 3.7 Effects of carbenoxolone, BX363A, pen ic illin  G, 
ethanol and indomethacin on the incorporation of 
N -acety l-[. H]glucosamine into an acid-precipitable  
fraction of ra t gastric mucosal scrapings
Compound
Carbenoxolone 
(7 days)
Incorporation Rate 
nmol x lO -4 /m g  giycoprotein/4h.
% change 
from control
Control Treated
58.82 + 4.76(6) 85.28 + 5.20(6) + 51%0/  * *
Carbenoxolone 56.44 + 6.84(6) 178.76 + 47.36(6) + 215% *
(14 days)
BX363A 4 8 .0 2 + 4 .1 0 (6 ) 6 4 .7 5 + 1 .6 2 (6 ) +35% * *
P enic illin  6 64.26 + 4.74(5) 8.24 + 1.58(5) -  87% * * *
Ethanol 54.78 + 3.11(6) 16.39 + 0.82(6) 0/ * * *
Indomethacin 31.24 + 5.36(6) 66.18 + 7.79(6) +112%**
Results are shown as means + S.E.M. of the number of observations 
shown in parentheses.
Students't-test *  P < 0.05, * *  P < 0.01, * * *  P < 0.001.
of 87% and 70% respectively. Associated with this decrease haemorrhagic 
areas were observed in a ll of the stomachs from rats treated with 
ethanol and in the stomachs of five of the six rats treated with 
pen ic illin  G. Haemorrhagic areas were also seen in the stomachs of 
a ll of the rats treated with indomethacin. In this case, however, 
the erosions were not associated with a decrease but an increase in 
the incorporation rate of 112%.
Effects of Ethanol on the Incorporation of N -acetyl-r3Hl-glucosamine 
into acid precipitable glycoproteins during a five  hour period a fte r  
dosing
The effect of ethanol on glycoprotein synthesis in the gastric  
mucosa was further studied by determining the rate of incorporation
i
of N -acety l-[3H]-glucosamine, 1, 2, 3, 4 and 5 hours a fte r a single dose 
(1.9mg/kg, 1ml 35% v/v by intubation). Mucosal preparations from 
animals which had received a sim ilar amount of water by intubation 
were assayed at the same time intervals. The results are shown in 
Table 3.8 and Fig. 3.7.
I t  can be seen that alcohol pretreatment caused a significant 
reduction of 61% within one hour of dosing. The percentage change 
from the controls however decreased up to the th ird  hour from dosing 
when the inhibition was only 4%. After this time the difference 
increased until a fter five  hours there was a significant inhib ition  
(67%) in the rate of incorporation. This reduction in the percentage 
change from the controls is due to a decrease in incorporation by the 
control preparations, in which the rate of incorporation was reduced 
significantly a fter 2 hours compared to the f i r s t  and f i f th  hour, and 
also to an apparent increase in incorporation into mucosal preparations 
from alcohol treated rats in which the rate at 3 hours was s ign ifican tly
Table 3 .8 The effects of ethanol on the incorporation of
X
N-acetyl [ H]glucosamine 1,2 ,3,4 and 5h a fte r dosing
Time from Incorporation Rate Change from
cfosi ng nmo I /1 0“4/mg g lycoprotei n/4h control %
Control Alcohol Treated
1 hr 50.12 + 4.07(5) 19.46 + 4 .9 3 (5 )**  -  61%
2 hr 35.45 + 3.37(5) 26.78 + 7.34(5) -  24%
3 hr 37.98 + 4.59(5) 36.27 + 5.63(5) -  4%
4 hr 39.07 + 5.75(5) 29.62 + 3.59(5) -  24%
5 hr 53.43 + 6.31 17.81 + 4 .0 7 (5 )***  -  67%
Results are shown as means + S.E.M. of the number of observations 
shown in parentheses.
Students *t ‘ test * *  P < 0 .0 1 ,***  P < 0.001.
Control preparations: Rate at 2h V 1 and 5h P < 0.05.
Alcohol treated: Rate at 3h V 1 and 5h P < 0.05.
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greater than those at one and five hours.
Effect of prostaglandin pretreatment on the rate of incorporation of 
N -acetyl-f3Hl-glucosamine into ra t gastric mucosal scrapings
Prostaglandins E-j, Eg* 15-R-15 methyl PGEg methyl ester, 16,16 
dimethyl PGE£ and AY22469 were administered to rats as indicated in 
Table 3.6. The animals were sacrificed five hours a fte r dosing and 
the incorporation assay carried out. The results are shown in Table 
3.9.
All of the prostaglandins, with the exception of PGE-j caused
significant increases in the rate of uptake of N-acetylglucosamine.
The most potent prostaglandin in this system was the synthetic
analogue of PGE2» 16,16 dimethyl PGEg which resulted in a 63%
increase in incorporation rate over the controls. This compound
is followed in order of potency by PGE j^ 15-R-15 methyl PGE^  methyl
ester and AY22469 with increases of 52%, 50% and 22% respectively.
Prostaglandin E^  showed an increase of 30% over controls but this
trend did not achieve s ta tis tic a l significance.
«
The Effects of anti-ulcerogenic and ulcerogenic drugs separately and 
in combination on the rate of incorporation of N -acety l-f3Hl-glucosamine 
into an acid-precipitable fraction of rat gastric mucosa
The effects of carbenoxolone, PGE^  and PGEg separately and in 
combination with indomethacin on the uptake of hexosamine were 
determined in rats starved for 24 hours in three separate experiments.
Carbenoxolone was administered for seven days in the drinking 
water (25mg/kg/day), control rats received water only. For the last 
24 hours of this dosing period food was withdrawn from both control
- 106 -
Table 3. 9. Effects of prostaglandins on the incorporation of
O
N-acetylf H]glucosamine into an acid-precipitable  
fraction of rat gastric mucosal scrapings.
Prostaglandin
PGE.
Incorporation Rate Change from
nmol x 10-4/mg glycoprotein/4h control (T)
Control 
38.98 + 4.08(6)
Drug Treated 
50.61 + 7 .0  (6) + 30% N.S
PGE, 3 8 .9 8 + 4 .0 8 (6 ) 5 9 .4 3 + 4 .0 7 (6 ) + 5 2 % **
15-R-l5 methyl 42.83 + 2.15(6) 
PGE2 methyl ester
16,16 dimethyl 42.83 + 2.15(6)
pge2
AY 22469 46.81 + 1.59(6)
64.07 + 2.83(6) + 50%
69.83 + 3.05(6)
0/  ie"k
+ 63% * *
5 7 .1 4 + 1 .0 6 (6 ) +22%
Results are shown as means + S.E.M. of the number of observations 
shown in parentheses.
Students't-test *  P < 0.05, * *  P < 0.01, N.S. not s ign ifican t.
and treated animals. Prior to k il lin g , ha lf the rats in each group 
received indomethacin (lOmg/kg, 0.2ml 3% v/v ethanol) by intubation. 
The remaining animals were intubated with solvent only.
Prostaglandins E-j and Eg (0.15mg/kg in 0.2ml 3% v/v ethanol) 
and indomethacin (lOmg/kg in 0.2ml 3% v/v ethanol) were administered 
to rats which had been previously starved for 24 hours. Further 
groups of animals were dosed simultaneously with PGE-j and indomethacin 
(0 .15mg/kg and lOmg/kg respectively in 0.2ml 3% v/v ethanol) and PGEg 
and indomethacin at the same dose levels. Control animals were 
intubated with 3% v/v ethanol (0.2ml) only. Animals were k ille d  5 
hours a fter dosing and the incorporation assays carried out. The 
results of these studies are shown in Tables 3.10 3.11 and 3.12.
The control rates of incorporation in these studies were very 
much lower than the control rates seen in comparable experiments, 
4.44±0.17 compared to 42.87±1.31 n mol x 10~Vmg glycoprotein/4h, in 
which a 24 hr starvation period was not used. These results indicate 
that starvation is a potent inh ib itor of the incorporation of 
hexosamine.
In previous experiments in vivo dosing with PGE-j, PGEg, carben­
oxolone and indomethacin resulted in increased rates of incorporation 
of N-acetylglucosamine into acid precipitable glycoproteins. In 
these studies with starved rats the increase caused by carbenoxolone 
was greatly reduced (increase of 12% over controls) and did not 
achieve a s ta tis tic a lly  significant difference.
The increase in uptake of N-acetylglucosamine a fte r indomethacin 
treatment was again accompanied by the appearance of haemorrhagic areas 
in the stomach. The appearance of these erosions was prevented by 
simultaneous administration of PGEg. Also the rate of incorporation
Table 3 .10
Drug treatment 
PGE1
Indomethacin
PGE, + 
Indomethacin
The effects of PGE-j and indomethacin separately 
and in combination on the incorporation of 
N-acetyl j^Hlglucosamine into an acid precipitable  
fraction of rat gastric mucosa
Incorporation Rate Change Presence of
nmol x TO-4/mg glycoprotein/4h from haemorrhagic
areas
0/3
4 .5 3 + 0 .3 8 (3 )  6.04 + 0.98(3) N.S. +33% 3/3
4 .5 3 + 0 .3 8 (3 ) 3.56 + 0.51(3) N.S. -21% 2/3
control
Control Drug treated —
4 .5 3 + 0 .3 8 (3 ) 5.97 + 0.18(3) N.S. +32%
Results are shown as means + S.E.M. of the number of observations 
shown in parentheses.
Students't-test N.S. not significant.
Table 3. 11 The effects of PGEg and indomethacin separately and in
combination on the incorporation of N -acety l[H i glucosamine 
into an acid precipitable fraction of rat gastric mucosa
Drug treatment Incorporation Rate Change from
nmol x lQ-4/mg glycoprotein/4h control %
Control Drug treated
PGEg 3 .9 7 + 0 .2 4 (3 )  5 .4 5 + 0 .1 8 (3 )* *  +37%
Indomethacin 3.97 + 0.24(3) 6.22 + 0 .23(3 )** +57%
PGEg + 3 .9 7 + 0 .2 4 (3 ) 3.95 + 0.21(3)N.S. 0
Indomethacin
Results are shown as means + S.E.M. of the number of observations 
shown in parentheses.
Students't-test, * *  P < 0.01, N.S. not significant.
Presence of 
haemorrhagTc 
areas
0/3
3/3
0/3
Table 3.12 The effects  of carbenoxolone and indomethacin
separately and in combination on the incorporation 
of N-acetyl [^Hlglucosamine into an acid precipitable  
fraction of ra t gastric mucosa.
Drug treatment Incorporation Rate Change from Presence of
nmol x 10"4/mg glycoprotein/4h. control ¥  haemorrhagic
areas
Control Drug treated
Carbenoxolone 5.01 + 0.31(3) 5.62 + 0.12(3)N.S. +12% 0/3
Indomethacin 5 .0 1 + 0 .3 1 (3 )  6 .7 9 + 0 .3 1 (3 )* *  +36% 3/3
Carbenoxolone + 5.01 + 0.31(3) 8.07 + 0 .19 (3 )*** +61% 3/3
Indomethacin
Results are shown as means + S.E.M. of the number of observations shown 
in parentheses.
Students vt'-test: * *  P < 0.01, * * *  P < 0.001, N.S. not s ign ifican t.
Comparison of indomethacin treated with indomethacin and carbenoxolone 
treated, P < 0.01.
by these stomachs was at the control level. The results with PGE^  
were again inconclusive. Simultaneous administration with indomethacin 
prevented erosion formation in one of the three stomachs and resulted 
in a reduction (21%) in the incorporation rate of N-acetylglucosamine. 
This reduction was not s ta tis tic a lly  significant.
In contrast to PGEg and PGE-j a combination of carbenoxolone and 
indomethacin resulted in an incorporation rate that was sign ifican tly  
greater than the control rate and the rate a fte r indomethacin treatment 
In this experiment, seven days pretreatment of rats with carbenoxolonei
did not prevent the appearance of gastric erosions caused by indomethaci
Analysis of Radiolabelled Rat Gastric Mucosal Glycoprotein By Con- 
canavalin A-Sepharose and Sephadex G-200 Gel Chromatography
The water soluble component of ra t gastric mucosal glycoprotein, 
purified by a ff in ity  chromatography on Concanavalin A-sepharose, 
was shown to consist of two d istinct components when chromatographed 
on Sephadex G-200 (Fig. 3 .8 ). These components had peak elution  
volumes of 55ml and 96ml. Using the calibration curve for the 
column (Fig. 3.9) i t  can be seen that the f i r s t  peak had an elution  
volume sim ilar to that of Blue Dextran 2000 (M.W. 2x 106) which is 
to ta lly  excluded by the Sephadex gel. The molecular weight of this 
component is therefore in excess of one m illion. The lower molecular 
weight component has an apparent molecular weight in the order of 
120,000.
The extent of incorporation of N -acety l-[3H]-glucosamine into  
the two peaks was found to be identical. The specific a c tiv ity  of 
the glycoprotein eluted between 39 and 60ml in the f i r s t  peak was 
44±0.91 dpm/yg and that eluted between 81 and 117ml in the second
(6rt)  ULa^o^d
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peak was 43+1.21 dpm/pg.
Two peaks with identical elution volumes were also seen (Fig. 3.10) 
when purified water soluble glycoprotein from the stomachs of rats 
treated with carbenoxolone (25mg/kg/day for seven days) was applied 
to the 6-200 column. These again corresponded to a high molecular 
weight molecule (greater than one m illion) and a lower molecular weight,' 
molecule (approx. 120,000). The specific ac tiv ities  for both components 
were again sim ilar, 103±4.5 dpm/pg (fractions 39 - 54ml) in the f i r s t  
peak and 107±3.98 dpm/yg (fractions 75 - 111ml) in the second. The 
specific ac tiv ity  of this water soluble glycoprotein from carbenoxolone 
treated rats is however considerably higher than that seen with control 
animals.
Hydrolysis of Purified Wafer Soluble Rat Gastric Glycoprotein from 
Control Incorporation Study
Thin layer chromatography of the hydrolysis products of water 
soluble glycoprotein isolated a fte r N -acety l-[3H]-glucosamine 
incorporation, showed (Table 3.13) the presence of galactose, gluco­
samine, galactosamine and N-acetylneuraminic acid. Radioactivity 
from N -acety l-[3H]-glucosamine was found associated not only with the 
isolated glucosamine spots but also with galactosamine and N-acetyl- 
neuraminic acid. Radioactivity was also seen in another component of 
the s ia lic  acid hydrolysis (R^0.32 in TLC system IV ). I t  is possible 
that this spot could represent N-glycolneuraminic acid. In contrast 
no radioactivity from incorporated N -acety l-[3H]-glucosamine was 
found in the neutral sugar hydrolysates.
-  116 -
Table 3.13 Identification of Radiolabelled sugars In hydrolysis 
mixtures of ra t gastric mucosal glycoprotein
Sugar T.L.C.
System
Rf. Presence in 
hydrolysate
Radioactive
Glucose
Galactose
Glucose
Galactose
Glucosamine
Galactosamine
Glucosamine
Galactosamine
N-acetyl-  
neuraminic acid
I
I
I
I
I
I
I I
I I I
IV
0.39
0.51
0.45
0.40
0.23
0.19
0.48
0.29
0.42
+++
+++
Details of T.L.C. systems given in Table 3.
3.3 . DISCUSSION
The studies reported in this chapter have shown that glycoprotein
synthesis in the rat stomach may be studied in v itro  over incubation
periods of at least four hours by following the incorporation of 
radio!abelled precursors into an acid precipi table fraction of gastric  
mucosal scrapings. Other s im ila rities  between incorporation into  
gastric discs (Chapter 2) and mucosal scrapings were also apparent.
In both cases uptake of sugar could be inhibited by cycloheximide 
(10 t|M). The optimum concentration of 1-glutamine in the incubation 
medium determined as 8mM for gastric discs by Shillingford (1975) was
also found to be optimal for mucosal scrapings.
Despite these s im ila ritie s , however, several important differences 
between the two techniques were observed. Although incorporation of 
hexosamine into acid precipi table glycoproteins of both gastric disc 
and mucosal preparations was inhibited by cycloheximide the degree of 
inhibition varied. Whereas a 35% inhibition occured with discs an 
inhibition of 51% was apparent in mucosal scrapings a fte r four hours 
of incubation. This difference implies that the mucosal preparation 
constitutes a more sensitive method for the determination of the 
in v itro  effects o f compounds on glycoprotein synthesis. The increased 
sensitiv ity  may be due to a greater accessibility of the mucosal cells  
towards the compound under study in a mucosal cell suspension.
The disc and mucosal preparations also differed with regards to 
the time dependency of incorporation. The 'lag phase' of one hour 
observed in disc preparations before the relationship between time 
and incorporation became linear did not occur when mucosal scrapings 
were used. Again this difference may result from absorption being 
fa c ilita te d  in a free cell preparation.
The most striking difference between the two incorporation 
systems was in the magnitude of the incorporation rates. In the rat 
stomach, using gastric discs, a rate of uptake of N -acety l-[3H]- 
glucosamine of 32±8 moles x 10 15/mg glycoprotein/h was seen compared 
to 1460±13 moles x 10 15/mg glycoprotein/h (mean ± S.E.M. of 22 
separate experiments) when mucosal scrapings were used. This increase 
of almost 50 fold must be due at least in part to the nature of the 
glycoprotein fraction isolated from the two preparations. Unlike 
that precipitated from gastric discs the fraction precipitated from 
mucosal scrapings contains macromolecules of mucosal origin only. The 
absence of muscular and connective tissue contaminants in this 
precipitate w ill result in the isolation of a fraction richer in 
mucosal glycoprotein and hence the observation of a higher rate of 
incorporation when expressed per mg glycoprotein. The same effect 
may be responsible for the greatly reduced scatter of results and 
consequently smaller standard errors of means generally noticed with 
mucosal scraping incorporations.
The isolation of a purer glycoprotein fraction cannot be wholly 
responsible fo r the 50 fold increase in the rate of uptake of hexosamine 
since the usual quantity of acid precipi table material from disc 
preparations (approximately 60 mgs.) is only six times the amount 
derived from scrapings (approximately 10 mgs.). Thus the actual rate 
of incorporation into mucosal scrapings must be higher. A higher 
effective concentration of N -acety l-[3H]-glucosamine, although equal 
concentrations were used in both systems, in the v ic in ity  of the 
glycosylation sites due to the removal of diffusion barriers may be 
responsible for this increase. Similarly oxygen which was shown to 
be necessary for incorporation w ill be more easily available in the 
homogenised than in the intact preparation.
Thus i t  can be argued that the incorporation of labelled 
precusors into mucosal scrapings constitutes a more accurate reflection  
of glycoprotein synthesis in the stomach than does the use of gastric 
discs. The increased sensitiv ity  should make i t  possible to observe 
subtle drug induced changes in glycoprotein synthesis which would 
remain undetected in the cruder disc preparation.
That the gut microflora do not contribute to the measured incor­
poration was proven by the observation that the uptake of labelled  
hexosamine by gastric washings was insign ificant, and cycloheximide, 
at a concentration inhibitory to growth and metabolism of yeasts 
(which constitute a large proportion of the rat stomach flo ra ) had 
no effect on the incorporation rate. In sim ilar incorporation studies 
using sheep colonic mucosal scrapings (Allen and Kent, 1968) and rat 
small intestinal slices (Lukie and Forstner, 1972) i t  has been shown 
that the microflora in these organs do not play a significant role 
in the uptake of labelled sugars during the f i r s t  four hours of 
incubation.
Addition of p e n ic illin  G to the incubation medium did lead to 
a reduction (30%) in the incorporation rate a fte r 4h incubation.
However administration of this drug to animals for 7 days prior to 
k illin g  also caused a marked reduction in the incorporation rate 
coupled with the appearance of erosions in the stomachs of the 
treated animals. I t  is therefore lik e ly  that the decrease in incor­
poration caused by addition of the compound in vitro  is due to an 
effect on mucosal glycoprotein synthesis rather than an inhib ition  
of bacterial growth.
That N -acety l-[3H]-glucosamine is incorporated into glycoproteins 
was demonstrated by the studies using Concanavalin A-Sepharose and
Sephadex G-200 chromatography in which the isolated radioactivity  
coincided with protein concentration. The label although mainly 
associated with N-acetylglucosamine was also shown to be present as 
N-acetylneuraminic acid and N-acetylgalactosamine. The incorporation 
of N-acetylglucosamine as s ia lic  acid has previously been demonstrated 
in studies on the biosynthesis o f tracheal mucins in the ra t (Gallagher, 
1976) and such interconversions are compatible with the scheme for the 
biosynthesis of aminated precursors of glycoprotein oligosaccharides 
shown in Fig. 3.11.
I t  is also theoretically possible for N-acetylglucosamine to be 
converted to neutral sugars and incorporated as such. However, the 
results obtained indicate that this does not occur in the present 
assay. Such an interconversion would require deacetylation and 
deamination of N-acetylglucosamine-6-phosphate. The deamination 
reaction:
Glutamate
%
Glucosamine-6-phosphate — Fructose-6-phosphate
— ►Glutamine
is unlikely to occur in the incubation medium to any great extent due 
to the high concentration of glutamine (8mM) present.
The elution volumes of the two components of water soluble 
gastric mucosal glycoprotein on Sephadex G-200 suggest that they have 
molecular weights in excess of 1 x 106 and in the region of 1.2 x 105. 
Similar results were obtained by Allen and Snary (1972) who isolated  
glycoprotein fractions of molecular weight 2 x 106 and 1.1 x 105from 
the water soluble mucosubstance of porcine gastric mucosa by caesium 
chloride density centrifugation. In the pig these high and Tow molecular 
weight glycoproteins had sim ilar chemical analyses, blood group 
ac tiv ities  and biosynthetic patterns (Snary and Allen, 1971, 1972) and
Acetyl-CoA Fructose-6-phosphate
t
Glutamine
il utamate
N-acetyl glucosamine «i—* Glucosamine
ATP ►
N-acetylglucosamine-6-phosphate«—  Glucosamine-6-phosphatei
Acetyl -  CoA
N-acetylglucosamine-1-phosphate
i
UTP
CMP-N-acetylneuraminic acid
+  CTP
N-acetylneurami ni c aci d-9-phsophate
Phosphoenolpyruvate
N-acetylmannosamine-6-phosphate
« ATP
N-acetylmannosamine
t
UDP-N-acetyl glucosamine — ------------------------— ------ ------------ -----------
Jf Glycoprotein
UDP-N-acetylgalactomsami ne ♦
Figure 3.11 Amino sugar synthesis and activation in glycoprotein 
biosynthesis
these authors have suggested that the high molecular weight 
glycoprotein is composed of repeating units of the low molecular weight 
glycoprotein. The finding that both high and low molecular weight 
fractions of water soluble mucosubstance from the rat had sim ilar 
specific ac tiv itie s  when labelled with N -acety l-[3H]-glucosamine 
indicates that the same situation might occur in this species.
I t  was shown that other sugars such as glucosamine, glucose, 
galactose and galactosamine were incorporated into acid precipitable  
glycoproteins but at markedly lower rates than N-acetylglucosamine. A 
number of reasons can be forwarded to explain this decreased level of 
uptake.
( I )  Differences in ac tiv ity  of specific glycosyl transferases. 
N-acetylglucosaminyl transferase may be the most active or abundant 
glycosyltransferase present in the mucosa.
( I I )  The enzymes required to form the activated derivative may 
not be present. The direct formation of UDP galactose from galactose- 
1-phosphate and UTP is not of major significance in mammalian tissues. 
The formation of this derivative is through the transfer of the UDP 
group of UDP-glucose to galactose-1-phosphate. Thus the incorporation 
of galactose w ill be dependent on the levels of UDP-glucose in the 
homogenate.
( I l l )  The position of the sugar in the glycoprotein biosynthesis 
chain. Glucosamine requires N-acetylation (Fig. 3.11) prior to 
incorporation and is therefore one step behind N-acetylglucosamine.
and (IV) The participation of the sugars in other metabolic pathways. 
This factor is of particular relevance to glucose and consequently 
galactose. Snary and Allen (1972) found that approximately 10% of
the added rad io ac tiv ity  was released as CO^  during the incorporation
of [ ltfC]-glucose into pig gastric mucosal scrapings.
In the presence of higher concentrations of the sugars the 
difference between N-acetylglucosamine and glucosamine was absent 
suggesting that the N-acetylglucosamine pathway is saturated at 
5 x 10 5M concentrations. This saturation may occur in the synthesis 
of activated precursors, at the glycosyltransferase level or in the 
av a ila b ility  of acceptors for the sugar precursors. However, studies 
both with high and low concentrations of sugar showed N-acetylglucosamine 
to be the best precursor for studying glycoprotein synthesis because 
of its  rapid incorporation and its  single metabolic fate i . e .  inclusion 
into oligosaccharides.
I t  was not possible to distinguish between ulcerogenic and a n ti- 
ulcerogenic compounds by the ir effects on incorporation of N-acetyl-  
glucosamine when they were added in v itro  to the incubations. Although 
indomethacin, ethanol and pen ic illin  G, in accordance with th e ir  
mucosal damaging properties, resulted in a decreased incorporation of 
N-acetylglucosamine the anti ulcerogenic prostaglandins and carbenoxolone 
fa iled  to cause an increase.
j
The prostaglandin effects, ranging from s ligh t inhibition (PGE-j 
and PGE2) to no effect (16,16 dimethyl PGEg and 15-R-15 methyl PGE )^ 
to s light stimulation (AY22469), coupled with the absence of a dose 
related effect suggest that the prostaglandins have no direct e ffec t 
on the individual enzymes involved in glycoprotein synthesis. Sim ilarly " 
the absence of any in v itro  effect over a wide range of concentrations 
of cyclic AMP (which has been suggested as a secondary messenger in  
prostaglandin a c tiv ity ) shows that prostaglandin induced increases 
in mucus synthesis (Fung et a l,  1974) are not mediated through an
a ffec t o f cyclic  AMP on the synthesising enzymes.
The studies with carbenoxolone showed that this compound may 
require normal subcellular organisation or a greater exposure time 
than is possible in the in v itro  incorporation assay to exhibit a 
stimulatory effect on incorporation. The concentration dependent 
inhibition of glycoprotein synthesis observed may be related to the 
potent uncoupling of oxidative phosphorylation reported for carben­
oxolone jin .vitro (Lindup, 1971).
The only compound which caused a marked increase in incorporation 
of hexosamines when added to the incubations was 1-glutamine, a 
component of the incubation medium. This increase may be because 
glutamine is used as an energy source for the biosynthesis of the 
nucleotide intermediates necessary for glycoprotein synthesis.
Such a role may also be important in considering the a b ility  
of glutamine to suppress the development of gastric lesions caused 
by aspirin (Okabe et jH , 1974) and stress (Takagi and Okabe, 1968) 
which are thought to be due to the development of local ischaemia 
and disturbances in the energy metabolism of the mucosal c e ll.
However, due to its  v ita l role in the synthesis of amino sugars and 
s ia lic  acids (Fig. 3.11) i t  is possible that the protective action 
of glutamine may be due to a direct stimulatory effect on glycoprotein 
synthesis. Further evidence in favour of this proposal is given by 
the finding that aspirin caused an inhibition of glutamine-fructose- 
6-phosphate transaminase in the rat (B o lle t, 1961) and led to a 
reduction in the concentration of protein bound hexosamines and s ia lic  
acid (Menguy and Masters, 1965).
In general a much better correlation between effects on the
incorporation rate of drugs and th e ir ulcerogenic or anti ulcerogenic 
properties was observed when the compounds were administered iji vivo 
before the in v itro  incorporation assay. Carbenoxolone produced an 
increase in the incorporation rate supporting the hypothesis that 
its  anti-u lcer properties are largely due to an effect on mucus 
synthesis.
The studies using Sephadex G-200 gel chromatography add further 
weight to the argument that the effect of carbenoxolone is on the 
degree of glycosylation of the glycoprotein rather than on the overall 
amount of glycoprotein synthesised. Pretreatment with the drug 
resulted in the isolation of two glycoprotein components with higher 
specific ac tiv ities  than those derived from control mucosal scrapings 
but did not appear to have any marked effect on the amount of glyco­
protein in these peaks.
Similarly i t  was shown that the stimulatory effects of carben­
oxolone appeared to be lim ited to the incorporation of amino sugars 
and did not include galactose on which carbenoxolone either had an 
inhibitory effect at low concentrations or no effect at higher 
concentrations. As discussed previously (Chapter 2) this d iffe re n tia l 
effect on incorporation rate implies that carbenoxolone results in 
the production of a modified glycoprotein containing increased 
amounts of N-acetylglucosamine, N-acetylgalactosamine and N-acetyl- 
neuraminic acid and less galactose. Further indirect evidence for  
the production of a glycoprotein with a modified oligosaccharide 
chain is provided by its  gel chromatographic pattern. Although
carbenoxolone caused increases in the rate of incorporation of 
hexosamines in the order of 100% there was no indication o f an increase 
in the molecular weight of the resulting glycoproteins compared to 
controls.
Similarly the increases in the incorporation rate of N-acetyl- 
glucosamine seen a fter pretreatment with prostaglandins which have 
reported anti-u lcer properties in animal and human studies suggest 
that these compounds may also exert some of th e ir beneficial action 
through an effect on mucus synthesis. This conclusion is supported 
by the work of Fung et al^  (1974b) who found that 15-R-15 methyl PGE2 
methyl ester caused an apparent increase in mucus synthesis in the 
stomachs of human gastric ulcer patients with a simultaneous increase 
in the rate of healing of the lesion.
In contrast alcohol and p e n ic illin  G led to a decrease in the 
rate of glycoprotein synthesis associated with the appearance of gastric  
lesions. Although direct evidence that the primary effect of these 
compounds is on mucus synthesis is not available, Eastwood and 
Kirchner (1974) have shown that within 15 miri. o f dosing with ethanol 
(10% v/v) the only abnormalites observed in the gastric mucosa of 
mice by electron and lig h t microscopy were a clumping of nuclear 
chromatinand a marked decrease in density of the endoplasmic reticulum. 
The apical membrane, surface mucous granules and mitochondria appeared 
normal. Primary damage to the endoplasmic reticulum implies that 
derangement of glycoproten synthesis, as evidenced by the incorporation 
studies is an early phenomenon in mucosal damage by ethanol and may 
subsequently lead to an impaired mucosal ba rrie r, development of 
erosions and the increase in back diffusion of hydrogen ions, as 
observed by Davenport (1967).
Factors such as stress and starvation were also shown to have 
an adverse effect on mucus synthesis. I t  is an accepted fact that 
prolonged stress e.g. restraint leads to impaired mucus production
and the appearance of ulceration in animals (Takagi and Yano, 1972). 
However, studies of incorporation rates during the period immediately 
following gastric intubation showed that even comparatively minor and 
acute stressful situations resulted in decreased glycoprotein synthesis 
for up to five hours. This finding indicates the need for care in the 
handling of animals used in such studies.
S im ilarly, in experiments in which a 24h period of starvation 
was employed, a dramatic decrease in incorporation rates was observed 
although no mucosal lesions were noted. Similar findings have been 
reported by MacDonald (1976) and this decreased mucus synthesis may 
be the cause of the gastric lesions observed a fte r more prolonged 
periods of starvation (Robert, 1963).
Seemingly anomolous results were produced by indomethacin 
treatment five hours prior to sacrifice . In treated animals erosions 
sim ilar to those caused by ethanol and p en ic illin  were observed. In 
indomethacin treated animals, however, these were accompanied by an 
increase in the rate of incorporation over the controls. This finding 
is not consistent with the reports of other authors who have shown 
indomethacin to cause a decrease in mucus synthesis, both by chemical 
analysis and in incorporation studies (Mengpy and Desbaillets, 1967, 
Shillingford, 1975). However, these workers examined the effects  
of indomethacin over considerably longer periods (daily doses fo r  
20 and 7 days respectively) than those used .in the present studies 
and i t  is possible that the increase seen a fte r acute dosage may 
represent a stimulation of glycoprotein synthesis in the normal 
tissue surrounding the lesions due to an 'ir r ita n t*  e ffec t of the 
drug.
There are indications that the same phenomena, although to a
lesser extent, may occur with ethanol (Fig. 3 .7 ). The rate of 
incorporation showed a tendency to increase towards that of the 
controls within three hours of a single dose.
The inhibitory effects of indomethacin on prostaglandin synthesis 
have been reported in a large number of animal tissues (Vane, 1971, 
Dembinska et a l , 1974). This antagonism also occurs in the gastric  
mucosa in which indomethacin has been shown to in h ib it prostaglandin 
synthetase (Main and W hittle, 1975) and consequently physiological 
events mediated by the prostaglandins, such as mucosal vasodilation 
(W hittle, 1976). Thus the gastric lesions caused by indomethacin may 
be the result of antagonism of prostaglandin synthesis and action.
This argument is supported by the finding that both the mucosal lesions 
and the apparent increase in incorporation rate caused by indomethacin 
were n u llifie d  by simultaneous administration of PGE2 and to a lesser 
extent PGE-j.
The presence of endogenous prostaglandins in the stomach and 
th e ir a b ility  to affect acid secretion and mucosal blood flow have 
led a number of authors (Vane, 1971, Frankhuijzen and Banta, 1975) 
to conclude that these compounds may have a physiological role in the 
maintenance of mucosal homeostasis . The observations that these 
compounds have a stimulatory effect on the incorporation of N-acetyl- 
glucosamine indicates that such a role may also include control of 
glycoprotein synthesis and the production of the mucus component of 
the gastric mucosal barrier.
The in a b ility  of carbenoxolone to antagonise the ulcerogenic 
effect of indomethacin or in h ib it the increase in incorporation rate 
observed a fter short term treatment with this drug does not preclude 
the existence of a common mechanism for the anti-u lcer and mucus
stimulating effects of carbenoxolone and the prostaglandins. I t  
has been shown in vitro  that carbenoxolone while having no effect 
on prostaglandin synthetase had potent inhibitory effects on 
prostaglandin 15-hydroxy-dehydrogenase and A^-reductase in guinea- 
pig lung (Peskar et al_, 1975) and human gastric mucosa (Peskar, 1975). 
Inhibition of the enzymes responsible for the breakdown of prosta­
glandins would not be expected to counter the effects of a synthetase 
inh ib itor. Thus i t  may be argued that at least some of the beneficial 
effects of carbenoxolone in the treatment of gastric ulceration may 
be through potentiation of endogenous E-type prostaglandins.
CHAPTER FOUR
THE EFFECT OF CARBENOXOLONE ON LYSOSOMAL STABILITY
4.1 INTRODUCTION 
Lysosomal History, Structure and Function
The name ‘ lysosomes1 has been given to a special group of cytoplasmic 
partic les, f i r s t  identified  and named by De Duve and his fellow workers 
(1955). De Duve's original studies were with rat liv e r , but lysosomes 
are now known to occur in most animal tissues, including the stomach 
(Ayulo and Forest, 1974).
Although lysosomes d iffe r  from tissue to tissue (Dingle, 1963) and 
between cells of the same tissue (Novikoff, 1963) certain generalizations 
apply. They are about 0.5 microns in diameter and are bound by a single 
outer membrane, possessing the dimensions and appearance expected for 
a ce llu la r lipoprotein membrane.
These cytoplasmic vesicles contain some forty hydrolytic enzymes, 
which exert maximal a c tiv ity  a t acid pH and are capable of digesting 
a ll the categories of macromolecules in the c e ll;  polysaccharides, 
proteins, glycoproteins, nucleic acids and lip id s . The major enzymes 
associated with lysosomes are shown in Table 4.1.
Formation of lysosomes containing digestive enzymes and substrate 
is preceded by two separate events. In the f i r s t ,  small hydrolase-rich 
sacs pinch o ff from the Golgi apparatus and give rise to primary 
lysosomes. In the second, infoldings of the cell membrane form vacuoles 
containing in tracellu lar material which is now endocytosed. These 
vacuoles (endocytic vacuoles) are the avenue to the in te rio r of the 
ce ll for substances which cannot cross the cell membrane (e .g . proteins).
A primary lysosome and an endocytic vacuole can then fuse and acquire 
a common membrane. The new hybrid vacuole (secondary lysosome) now
Table 4.1 The Major Enzymatic A ctiv ities of Lysosomes
(from Ho11zma n, 1976)
Lipids Acid lipase
i
Ceramidase
Phospholipases A-j and A^  
Sphingomyelinase
Esterases (active against th io l, indoxyl-, 'napthyl,
fa tty  acid and cholesterol esters)
Nucleic Acids Acid deoxyribonuclease
Acid ribonuclease
Acid phosphatase
Acid pyrophosphatase
Phosphodiesterase
Complex lip ids N-acetyl-a-galactosaminidase
Polysaccharides N-acetyl-a-glucosaminidase
Glycoproteins N-acetyl-3-hexosaminidase
Aspartylglucosylaminidase
Fucosidase(s)
Galactosidase (a and 3)
Glucosidases (a and 3)
Hyaluronidase
Iduronidase
Mannosidases (a and 3)
Neuraminidase
O-Seryl-N-acetyl-a-galactosaminidase
B-xylosidase
Aryl sulphatase (A and B)
Chondrosulphatase
Sulphamidase
Proteins Acid carboxypeptidase
Amino acid napthylamidase
Cathepsin A (probably carboxypeptidase)
Cathepsin B (B1 and B2; endopeptidases)
Cathepsin C (dipeptidylaminopeptidase)
Cathepsin D (acid "proteinase")
Dipeptidylaminopeptidase I I
contains endocytosed material and lysosomal hydrolases in close contact 
and subsequently the former becomes the substrate for the la tte r  (De Duve 
and Wattiaux, 1966). In tracellu lar materials to be digested are disposed 
of by the process of autophagy (De Duve and Wattiaux, 1966) in which 
part of the c e ll's  cytoplasm becomes segregated by a membrane which 
surrounds i t  and separates i t  from the rest o f the c e ll.  Here too the 
autophagic vacuole formed fuses with a primary lysosome and catabolism 
can take place.
Catabolism within the lysosome usually means breakdown of the 
material to the simplest units, i .e .  amino acids and sugars from glyco­
proteins, mononucleotides from nucleic acids and simple lip ids  and 
sugars from glycolipids. Catabolic products of a molecular weight 
smaller than 200 can usually diffuse out through the lysosomal membrane 
(Gorden, 1973) and be re -u tilised  by the c e ll.  Non-digestible remnants 
that cannot diffuse can be expelled by exocytosis which involves fusion 
of the secondary lysosome with the cell membrane and exteriorization  
of the lysosomal contents.
Lysosomes appear to be involved in a large number of normal 
physiological processes. Weber (1963) has shown that in the ta i l  of the 
developing tadpole of the South African frog (Xenopus laevis) the levels 
of cathepsin are elevated and increase as the ta il  regresses un til the 
stump contains large amounts of lysosomal enzymes and drops o f f .  A 
sim ilar mechanism is thought to apply to the resorption of bone by 
osteoclasts (Vaes, 1969). According to this view the hydrolases are 
excreted in bulk, by exocytosis, in the in trace llu la r resorption zone 
near the osteoclasts, where they exert an eroding action on the organic 
components of the bone matrix. Fragments released from the matrix by
this process may be taken up in osteoclasts by pinocytosis to be 
further digested in tra ce llu la rly .
Lysosomes play a major role in the catabolism of in trace llu la r  
(Segal, 1975; Dean, 1975) and extracellu lar (Gregoriadis, 1975) 
proteins and glycoproteins. The gastrointestinal tract has been 
proposed as a major s ite  for the degradation of glycoproteins (Hsu 
and Tappel, 1965; Robinson, 1969) and i t  has been suggested that part 
of their role in these organs is the digestion o f sloughed mucus and 
ep ithelia l cells to provide substrates for the synthesis of new cells  
and mucus (Gordis, 1966).
Degradation of glycoproteins, the major component of mucus, 
to individual sugars and amino acids involves the breakage of three 
types of bond; bonds between any two sugars, bonds between a sugar and 
amino acid in the polypeptide backbone, and bonds between amino acids.
Such a breakdown would require the action of a large number of hydrolases 
as is found within the lysosomes. Figure 4.1 shows the structure of 
an imaginary gastric glycoprotein containing galactose, N-acetyl-  
galactosamine, N-acetylglucosamine, N-acetylneuraminic acid and fucose, 
and some of the lysosomal enzymes which would be involved in its  
breakdown.
In view of the nature of the lysosomal contents i t  is hardly 
surprising that lysosomes have been implicated in a number of pathological 
processes. Involvement in the disease process may either be through 
a deficiency of one or more lysosomal enzymes, or through the effects  
on liv ing  tissue of hydrolases released via damaged membranes. However, 
evidence linking lysosomal disruption to disease processes is indirect, 
being based on experimental evidence, often without c lin ica l confirmation.
Figure 4.1 Hydrolysis of Gastric Glycoproteins by 
Lysosomal Enzymes
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1. Neuraminidase (Yaha and Carubelli, 1967)
2. N-acetyl-a-D-galactosaminidase (Weissmann and Fried oric i, 1966)
3. g-D-galactosidase (Sellinger et jH , 1960)
4. N-acetyl-B-O-glucosaminidase (Sellinger et a l , 1960)
5. a-l-fucosidase (Conchie and Hay, 1963)
6. a-D-galactosidase (Van Hoof and Hers, 1968)
7. Cathepsins (Vaes, 1973)
The best known examples of diseases associated with a deficiency 
or lack of lysosomal hydrolases (storage diseases) involve lip id s , 
polysaccharides and mucopolysaccharides. Thus, in Tay-Sachs' disease, 
hexosaminidase A ac tiv ity  is deficient (O'Brien, 1973) and the 
ganglioside accumulates in neurons and elsewhere (Terry, 1971).
In metachromic leukodystrophy aryl sulphatase A a c tiv ity  is lacking 
and bodies rich in cerebroside sulphate are prominent in g lia l cells  
(Austin, 1973; Eto et al_, 1974). In the Hurlers syndrome (gargoylism) 
ot-l-iduronidase (Bach et cH, 1972), 3-galactosidase and a-fucosidase 
(Van Hoof and Hers, 1968) may be deficient leading to an accumulation 
of mucopolysaccharides, and in Pompes disease (glycogenosis type I I )  
a-glucosidase is absent and abnormal deposits of glycogen are found in 
hepatocytes and muscle cells (Hers and De Barsy, 1973). A comprehensive 
review of inborn lysosomal diseases is available (Hers, 1973).
In various forms of a r th r it is , cartilage or bone matrices are 
extensively eroded. Synovial flu ids from a r th r it ic  jo ints show 
elevated levels of extracellu lar hydrolases (Caygill and P itkeath ly,
1966; Collins and Lewis, 1971). These observations coupled with the 
findings that acid hydrolases accumulate ex trace llu larly  during autolysis 
of explanted cartilage or bone (Fell and Dingle, 1963) have led to the 
concept that degradative aspects of the damage to connective tissue are 
due in large measure to abnormal release of lysosomal enzymes from cells  
of the perichondrium or synovium, from chondrocytes and from phagocytes 
that enter the damaged tissue. The involvement of lysosomal enzymes in 
the a r th r it ic  breakdown of connective tissue has been reviewed recently 
(Dingle, 1973).
The effects of a number of noxious agents on cells have been 
tentatively attributed to in trace llu la r release of hydrolases as a 
primary event. Proposals of this type have been made for the cytotoxic 
actions of bacterial endotoxins (Weissman, 1967) and the k illin g  of 
cells by photoreactive dyes or s ilica  (Ericcson et al_, 1974).
K illing of alveolor macrophages by inhaled fibres and subsequent 
repeated release from dead cells and re-uptake cells could possibly 
be a major factor in s ilico s is .
Involvement of Lysosomes in Gastric Ulceration
Another disease state in which lysosomes have been implicated is  
gastric ulceration. Ferguson et al_ (1972) found that gastric ulcers 
in restrained rats were associated with reduced mucosal levels of 
cathepsFn D, indicating rupture of lysosomal membranes and release o f 
enzymes. The action of these enzymes on protective mucus lin ing  
the stomach could be responsible for the 'underglycosylated' glyco­
protein apparent in gastric lesions.
Similar evidence exists for lysosomal involvement in drug induced 
gastric ulceration. Serotonin was found to induce gastric ulcers in  
rats , associated with a release of lysosomal enzymes (Ferguson e t la l , 
1973) and the non-steroidal anti-inflammatory drug phenylbutazone, a t 
ulcerogenic doses was found to accelerate the breakdown o f lysosomes 
in isolated stomach preparations from the ra t and rabbit (Lewis e t a l , 
1971).
Steroidal anti-inflammatory agents such as cortisone and prednisolone 
have also been shown to damage the gastric mucosa (Takagi and Abe, 1974). 
I t  would seem anomalous that the anti-inflammatory steroids and certain
non-steroidal anti-inflammatory agents such as phenylbutazone cause 
gastric lesions associated with lysosomal damage, since i t  is believed 
that the beneficial action of these drugs in inflammatory diseases 
such as a r th rit is  is due, at least in part, to lysosomal membrane 
stab ilization  (Nakanishi and Gato, 1975). However, the e ffec t on 
lysosomal s ta b ility  has been shown to be concentration dependent 
(Lewis et al_, 1970; Symons, 1971), causing stab ilization  at lower 
concentrations and lysis a t higher concentrations. Lewis (1970) has 
suggested that a local build up of drug concentration, following long 
term oral treatment and subsequent lab iliza tio n  of membranes may be a 
causative factor in the associated ulceration.
The Effect of Carbenoxolone on Lysosomal S tab ility
In studies using a r t i f ic ia l  vesicles, liposomes, i t  has been
shown that carbenoxolone has a biphasic effect on membranes. High
-3concentrations of the drug (greaterthan 10' M) cause lysis and lower
- f iconcentrations (10~ M) increase the s ta b ility  of liposomes (Symons, 
1976). Studies on the effects of carbenoxolone on the s ta b ility  of 
endogenous vesicle membranes are however lacking.
4.2 MATERIALS AND METHODS
Chemicals
Phenolphthalein glucuronide, p-nitrophenyl phosphate, p-nitrophenyl- 
N-acetyl-(3-D-glucopyranoside and Triton X-100 were obtained from the 
Sigma Chemical Company Ltd ., London. Carbenoxolone sodium was a g if t  
from Biorex Laboratories L td ., London. All other chemicals were 
Analar grade wherever possible and obtained from either B ritish Drug 
Houses L td ., Poole, Dorset, or the Sigma Chemical Company L td ., London.
Isolation of a Lysosome Fraction
The method used was a modification of Weissmann's (1965). Four male 
Wistar albino rats (body weight approx. 300 g) from the University of 
Surrey Breeding Unit, were k illed  by cervical dislocation and th e ir  
livers immediately removed, weighed and placed in ice-cold 0.25M sucrose. 
Between 30 and 40g of liv e r were obtained. The liv e r  was then mi heed 
fin e ly  with scissors (2-3 mm cubes) and 3-5g portions homogenised in 
0.25M sucrose using a Potter Elvejhdm homogeniser. All operations 
were carried out at 4°C. I t  was found that two up and down strokes with 
the pestle were suffic ient to form a homogenous suspension. This in it ia l  
suspension was diluted to a fina l concentration of 10% w/v  with 0.25M 
sucrose (300-400 ml, total volume).
This whole liv e r homogenate was centrifuged a t 750 gay for 10 min.
in an MSE Highspeed 18 centrifuge at 4°C. This sedimented the unbroken
ce lls , debris and nuclei leaving the cytoplasmic contents in suspension.
The p e lle t was discarded and the supernatant centrifuged at 20,000 gawav •
for 20 min. also in the MSE Highspeed centrifuge, which sedimented a 
'large granule' fraction containing unbroken lysosomes. The p e lle t was 
washed twice in 150 ml volumes of 0.25M sucrose. This involved careful
resuspension of the pe lle t and recentrifuging at 20,000ga„ for
a  V •
20 min. The washed pe lle t was fin a lly  suspended in ice-cold 0.25M 
sucrose containing 0,05 M tris-HCl buffer (pH 7 .4 ). 2 ml of sucrose-
buff er were added for every gram of liv e r used. This fin a l suspension 
was used in subsequent experimentation and w ill be referred to as the 
'lysosome* or 'lysosome rich* fraction.
The Effect of Carbenoxolone on lysosomal Enzyme Release
Portions (5 ml) of the lysosome suspension were added to 50 ml 
conical flasks, stoppered and shaken in a shaking water bath (Mickel) 
at 100 oscillations per min. Carbenoxolone was added as a small 
volume of aqueous solution. Appropriate controls were always run.
The time and temperature of incubation was 90 min. at 37°C and the 
pH of a ll experiments was 7.4 (tris-HCl buffer).
The level of free enzymes present in fresh lysosome suspensions 
before incubation was always measured by centrifuging a small volume 
(5 ml) a t 20,000gQV for 20 min using an MSE Superspeed 50 centrifuge 
and a 10 x 10 ml rotor and assaying the enzyme a c tiv ity  in the super­
natant. In a sim ilar way the amount of free enzyme a fte r  any treatment
the lysosomal suspension received could also be measured. The total
amount of enzyme that could be released from the lysosomes was measured
by subjecting them to the ly t ic  action of 0.1% Triton X-100, a non- 
ionic detergent, and measuring enzyme levels a fte r centrifugation.
Enzyme Assays
(1) Acid phosphatase (orthophosphoric monoester phosphohydrolase)
A modification of the method of Huggins and Talahay (1945) was used 
Portions (0.5 ml) of p-nitrophenylphosphate (0.015M) and 0.5 ml Sorensen 
c itra te  buffer, 0.09M, pH 4.8 were mixed together and lOOyl of the
supernatant to be assayed added. The reaction mixture was incubated 
at 37°C for 30 min (TOO oscillations/min) a fte r which 5 ml of 0.1 M 
NaOH were added. This stopped the enzymic reaction and the released 
p-nitrophenol was determined at 400 nm in a Cecil CE272 spectrophotometer. 
Appropriate reagent and supernatant blanks together with a p -n itro - 
phenol standard were always run. The standard calibration curve for 
p-nitrophenol is shown in Fig. 4.2 (a ).
( i i )  g-Glucuronidase (g-D-glucuronide glucuronohydrolase)
A modification of the method of Talahay et eH (1946) was used. 
Portions (0.5 ml) of phenolphthalein glucuronide (0.0015M) and 0.5 ml 
acetate buffer (0.2M, pH 4.5) were mixed together and lOOyl o f the 
supernatant to be assayed added. The reaction mixture was incubated 
at 37°C for 30 min (100 oscillations/min) a fte r which 5 ml o f 0.2M glycine 
buffer, pH 10.4, were added. This stopped the enzymic reaction and 
developed the colour o f released phenolphthalein which was determined 
at 540 nm. The standard calibration curve for phenolphthalein in shown 
in Fig. 4.2 (b ).
( i i i ) N.-acetyl glucosaminidase(3-2-acetimido-2-deoxy-D-glucoside
acetamidodeoxy-glucohydrolase)
This was estimated using p-nitrophenyl-N-acetyl-3-D-glucopyranoside 
as substrate (Caygill and Oevons, 1965). Portions (0.5 ml) of a 0.0015M 
solution of the substrate and 0.5 ml of 0.2M acetate buffer, pH 4 .5 , were 
mixed. lOOyl of the supernatant to be assayed was added. The conditions 
of incubation and estimation were exactly as for acid phosphatase.
Protein Assay
Suitable dilution of the lysosomal suspensions were routinely  
measured for their protein content, as an index to which other parameters 
could be referred. The spectrophotometric method of Lowry et al (1951)
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Fig. 4.3 Standard calibration curve for the estimation of 
protein using the method of Lowry et al (1951)
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Bovine serum albumin was the protein standard used.
was used with bovine serum albumin as a standard. The standard 
calibration curve is shown in Fig. 4.3.
4.3 EXPERIMENTAL AND RESULTS
(a) Time course of enzyme release
A lysosomal preparation (60 ml) in 0.05M tris-HCl buffered 0.25M 
sucrose at pH 7.4 was incubated at 37°C (100 oscilla tions/m in). Samples 
(5 ml) were removed at various time points, centrifuged and the a c tiv ity  
of acid phosphatase in the supernatant determined. Figure 4.4 shows 
the release of acid phosphatase over a 5-hour period, the a c tiv ity  
being expressed as yg p-nitrophenol formed from p-nitrophenyl phosphate 
per mg protein in the lysosomal fraction. I t  can be seen that the 
amount of enzyme released increases with time, the rate of release 
being greater in the f i r s t  hour than in the subsequent 4 hours. Even 
a fte r 5 hours of incubation the level of released enzyme did not reach 
that which was released by freezing and thawing a sample six times.
Although the results in Figure 4.4 were related to the protein 
concentration of the lysosomal suspension i t  was found a fte r further 
experimentation that the amount of lysosomal enzyme in d ifferen t 
lysosomal preparations was in no way proportional to the protein 
concentration of the fraction. I t  was therefore necessary to run s tr ic t  
controls with every experiment and for comparison to express a l l  increases 
or decreases in enzyme a c tiv ity  as a percentage of these controls.
(b) Effect of Triton X-100 on enzyme release
Aliquots (5 ml) of a lysosomal suspension (in  0.05M tris/HC l 
buffered 0.25M sucrose, pH 7.4) were placed in 50 ml conical flasks.
To these was added 50yl of aqueous trito n  X-100 solutions over a range
yg 
p-
ni
tr
op
he
no
l 
fo
rm
ed
/m
g 
pr
ot
ei
n
-  145 -
ig. 4.4 Time course of acidphosphatase release from a lysosomal fraction
320
280
Level reached by freezing and 
thawing a sample 5 times
240
200
160
120
80
40
1 2 3 4 5
Time in hours
-  146 -
Fig. 4.5 The effect of Triton x-100 concentration on the acid phosphatase 
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of concentrations to give fina l concentrations in the flasks of
-6 —1 v10” — 5 x 10" % /v trito n  X-100. Appropriate aqueous controls
were also run. The flasks were incubated as normal for a period
of 90 minutes. Free acid phosphatase levels were measured in i t ia l ly
and a fte r incubation. Figure 4.5 shows the results obtained.
Triton X-100 is capable of releasing acid phosphatase from the
lysosomes and this effect was concentration dependent. The c r it ic a l
—3 vconcentration of Triton X-100 appears to be in the region of 10 % /v .  
Between this concentration and 0.1% v/v tr ito n  the lysosomes are 
very sensitive to concentration changes. Above concentrations of 0.1% 
very l i t t l e  increase was noted.
The Effects of Carbenoxolone on lysosomal enzyme release
A series of experiments was conducted using a range of carbenoxolone
concentrations. The carbenoxolone was added in a small volume of
aqueous solutions (50yl) to conical flasks containing 5 ml of lysosomal
suspension (in  0.05M tris-HCl buffered 0.25M sucrose, pH 7 .4 ) , to give
-3 -8a final concentration range of 10 -  10’  M. Aqueous controls were run
simultaneously. The flasks were incubated normally, the free levels of 
acid phosphatase, 3-glucuronidase and N-acetyl glucosaminidase being 
measured before and a fte r incubation. The results are shown in Figures 
4.6 , 4.7 and 4.8.
I t  can be seen that carbenoxolone appeared to have a biphasic
effect on the s ta b ility  of ra t liv e r lysosomes as measured by the
release of the three enzymes studied. Lysis of the lysosomes leading
-4to increased enzyme leakage occurred with high concentrations (10 M 
and above). Lower concentrations showed either a s tab iliz ing  effec t 
or no significant effect at a l l .  Maximum stabilization always occurred
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~5in the region of 10 M carbenoxolone.
The effect of the same range of carbenoxolone concentrations on 
thethermal s ta b ility  of acid phosphatase, 3-glucuronidase and N-acetyl- 
glucosaminidase was also studied to determine whether this reduction 
in enzyme levels was due to inhibition of the enzymes rather than 
a stabilization o f the lysosomal membrane preventing or retarding 
release of the enzymes.
An enzyme rich supernatant was obtained by centrifuging a 
lysosomal preparation which had been frozen and thawed six times.
Portions (2 ml) were incubated at 37°C with a range of carbenoxolone 
concentrations (10“ -10“ M) water alone being added to control incubations. 
Enzyme ac tiv ity  of acid phosphatase, 3-glucuronidase and N-acetyl- 
glucosaminidase was measured before and a fte r incubation. The results 
are shown in Table 4.2 expressed as a percentage of the a c tiv ity  in 
control incubations.
The results show that carbenoxolone tended to cause a reduction in
the ac tiv ity  of the three enzymes over the concentration range used.
A concentration dependency for this decrease was not apparent but the
highest degree of inhibition was always apparent at the highest
-3concentration used, namely 10 M carbenoxolone.
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Table 4.2
Carbenoxolone
The effect of carbenoxolone on the thermal s ta b ility  
of acid phosphatase, 3-glucuronidase and N-acetyl- 
glucosaminidase from ra t liv e r lysosomes
Enzyme ac tiv ity  a fte r 90 min. incubation 
{% of control va'luesj
Acid phosphatase 3-glucuronidase N-acetylglucos-
aminidase
100 100 100
91 95 89
95 89 93
91 96 91
93 83 97
71 81 76
Results are expressed as the means of duplicate samples and have 
been corrected for the free enzyme a c tiv ity  apparent before incubation.
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Fig. 4.9 The e ffec t of carbenoxolone sodium on the s ta b i l i ty  of ra t l iv e r
lysosomes
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Results corrected for compounds effect on free enzyme a c tiv ity  
(Acid phosphatase - closed triangles; e-glucuronidase - closed 
circles; N-Acetylglucosaminidase - closed squares).
4.4 DISCUSSION
The lysosome preparation used in these experiments was from liv e r ,  
for reasons of y ie ld  per gram of tissue, rather than the stomach, and 
was impure. No attempt was made to separate mitochondria from lysosomes.
The apparatus and techniques needed to successfully accomplish this 
separation, resulting in a purer and more reproducible preparation are 
given by Beaufay (1969) and Dingle and Barret (1969). Yet, despite the 
extremely elaborate procedures used, even these authors have fa iled  to 
produce a 100% pure lysosomal preparation.
However, despite the impurity of the fraction , specific lysosomal 
enzymes were studied and i t  could be argued that the in v itro  experiments 
conducted were a t least as relevant to the in vivo situation as a purer 
lysosomal preparation would have been. The prepared fraction contained 
a large number of intact lysosomes which could be lab ilized  by incubation 
at 37°C or to a greater extent by treatment with the non-ionic surfactant 
Triton X-100.
These studies show that concentration is o f c r it ic a l importance 
when considering the effects o f carbenoxolone on lysosomes. The drug 
possesses a biphasic e ffect on lysosomal s ta b ility , measured by the 
release of acid phosphatase, 3-glucuronidase and N-acetylglucosaminidase.
High concentrations (10 and above) caused lysis while lower concentrations 
showed either a stabilizing effect or no e ffect at a l l .  At 10~5M 
concentrations maximum stabilization occurred and although the degree 
of stab ilization  was never more than 12-22% at this concentration the 
results are highly significant.
The inhibitory effect of carbenoxolone on the free lysosomal
enzymes must account for some of the observed decrease in enzyme
ac tiv ity  otherwise attributable to s tab iliza tio n . Such an
inhibition could be due to carbenoxolone binding to the enzyme
protein, perhaps obscuring the active s ite . When, however, the
loss of enzyme ac tiv ity  due to s tab ilization  was corrected for that
due to enzyme inhibition a sim ilar pattern is produced for a l l  the
enzymes (Figure 4 .9 ), The biphasic effect is s t i l l  apparent and
stab iliza tio n , although to a lesser extent, may s t i l l  be seen at 
-510 M carbenoxolone, higher concentrations of the drug producing an 
even more marked ly t ic  e ffec t.
There have been a number of reports linking lysosomal enzymes 
with ulceration of the gastro-intestinal tra c t. Ulceration of the 
caecum in guinea pigs by carrageenan has been attributed to lysis  
of macrophage lysosomes due to ingestion of this compound (Abraham 
et al» 1974). S im ilarly, in the stomach gastric damage is associated 
with a leakage of lysosomal enzymes.
Gastric ulcers in restrained rats are associated with reduced 
mucosal levels of the enzyme cathepsin D (Ferguson et a l , 1972), as 
are ulcers induced by seretonin (Ferguson al_» 1973), and acute
i
alcohol intoxication which was shown to cause gastric lesions in 
rats (Chapters 2 and 3) is associated with abnormal f ra g il ity  of 
lysosomes and discharge of enzymes (Geokas and Rinderknecht, 1973). 
Sim ilarly, phenylbutazone and azopropazone were shown to induce gastric 
lesions associated with lysis of gut lysosomes, the more potent ulcer­
ogenic effect of phenylbutazone being associated with a more marked 
effect on lysosomal leakage (Lewis e t al_, 1971). In contrast to
these results prostaglandin E-j which has been shown to have an a n ti-  
ulcerogenic effect (Robert et al_, 1968) has been shown to decrease the 
leakage of lysosomal enzymes in the gastric mucosa (Ferguson et a l,1973).
These results do not indicate whether release of lysosomal 
enzymes is causative in the production o f the lesion or merely an 
indication of tissue damage. Although even i f  secondary, the release 
of lysosomal enzymes with their considerable digestive capabilities  
would aid the development of the lesion. However, in v itro  studies 
have shown that phenylbutazone and azopropazone have a direct ly t ic  
effect on isolated liv e r  lysosomes (Lewis et a l ,  1971). Furthermore, 
prostaglandin E^  has been shown to have a direct s tab iliz ing  effect on 
lysosomes from human polymorphonuclear leukocytes (Weissman et a l , 1971), 
canine hepatocytes (Ra-flo jet aj_, 1973) and ra t gastric mucosal cells  
(Ferguson et ajj_, 1973).
Sim ilarly to prostaglandin E^  carbenoxolone was shown to cause a
reduction in the release of lysosomal enzymes from ra t liv e r  and i t  may
be postulated that such an effect on gastric mucosal lysosomes could
play a role in the anti-ulcerogenic action of this drug. Studies
showed a stab ilization  of no greater than 22%. This, however, was in
an in v itro  situation and the effect under jm vivo conditions of pH
etc. could be more dramatic. The membrane stabilizing role of carbenoxolone
- f iis supported by the work of Symons (1976) who found that 10“ M concentrations 
of the drug resulted in decreased permeability of phosphatidylcholine and 
phosphatidylcholine:cholesterol liposomes.
A sim ilar stab iliz ing  mechanism has been proposed fo r the a n ti­
inflammatory corticosteroids used in the treatment of a r th r it is . These 
also show a biphasic effect on lysosomal s ta b ility  (Lewis, 1970; Symons,
1971). Anti-inflammatory drugs have however been implicated in 
gastric mucosal damage and Lewis (1970) has suggested that this  
could be due to an accumulation of the drugs in the v ic in ity  of 
the lysosomes during long term therapy, thereby producing ly t ic  
concentrations, lyosomal rupture and ulceration. Consequently
i t  might be expected that carbenoxolone with a lower in v itro
-5 -4ly t ic  concentration. 5 x 10 M compared to 5 x 10 M (Symons, 1971),
would produce gastric lesions in c lin ica l use. However, due to its
rapid absorbtion and high degree of binding to plasma proteins, an
average level of 15^g/ml of plasma, equivalent to 75% of a therapeutic
dose (100 mg), within two hours of dosing in humans (Baron e t al_, 1975)
i t  is unlikely that the drug would reach ly t ic  concentrations in the
v ic in ity  of the gastric mucosal lysosomes.
Thus i t  may be postulated that lysosomal fra g il ity  is important in 
the genesis of drug induced ulceration in animals and possibly in 
chronic gastric ulceration in humans. Whether rupture of these 
organelles is a primary feature or secondary in aiding the development 
of the lesion,lysosomal stab ilization  could in part explain the 
beneficial action of carbenoxolone in the treatment of this disease. 
Such a stab ilization  could explain the decreased cell turnover noted 
by Lipkin (1970) and may explain in part, the increase in glycoprotein
i
synthesis which occurs a fte r carbenoxolone treatment.
CHAPTER FIVE 
GENERAL DISCUSSION
This chapter presents a view of the experimental work carried 
out, the conclusions drawn from i t  and suggestions for further work.
In view of the thermal and chemical conditions in the stomach 
which are optimal for tissue digestion i t  is pertinent to ask why 
gastric ulceration is not more common than i t  is . The answer lies  
in the remarkable a b ility  of the gastric mucosa to defend i ts e lf .
An ulcer may be considered to be the result o f an imbalance between 
the aggressive contents of the stomach and this defence a b il ity , and 
may result from an increase in the former or a decrease in the la t te r .
Until recently most studies on the pathogenesis of gastric  
ulceration and attempts a t treating the lesion have been concerned 
with the roles of acid and pepsin and antagonism of th e ir secretion 
or action. L itt le  attention was focused on the role of the 'mucosal 
barrier' in ulcer formation or treatment of the disease by its  
stimulation. Indeed as recently as 1973 a Medical Research Council 
specialist committee on gastoenterology stated that the role of mucus 
in peptic ulceration was worthy of research.
Mucous glycoprotein synthesis cannot be sa tis facto rily  studied 
in vivo because of the poorly understood and probably complex control 
mechanism involved. The unsuitab ility  of in vivo studies was illu s tra ted  
using the in v itro  assays based on the incorporation of radio-labelled  
precursors. Within an hour of an acute stress such as gastric intubation, 
glycoprotein synthesis was seen to decrease and did not return to normal 
levels until four hours. Such an effect of stress is certain ly not 
lim ited to the stomach and indicates the need for care in the handling 
of animals for use not only in studies on glycoprotein synthesis but 
in a ll biochemical work.
The three anatomical divisions of the human stomach were seen 
to incorporate N-acetylglucosamine at d ifferen t rates. Although i t  
is possible that the observed differences may indicate the synthesis 
of glycoproteins with d ifferent carbohydrate side chains by the three 
areas i t  is more probable that the difference is due to the distribution  
of mucus secreting cells throughout the stomach, the pyloric antrum 
having the highest concentration. The inverse correlation between 
the rate of mucus synthesis and the tendency towards ulceration 
in a particular anatomical subdivision lends support to the protective 
role of gastric mucus with regard to ulceration.
That a derangement of mucus synthesis is involved in gastric 
disease is shown by the studies on biopsy samples from diseased human 
stomachs. Incorporation of hexosamine is decreased in those areas of 
the stomach affected by the lesion but is normal throughout the rest 
of the stomach. Thus decreased rates of mucus synthesis were seen in 
the lesser curve of patients suffering from ulceration o f the lesser 
curve and in the antrum of g a s tritic  patients. S im ilarly , malignant 
changes of the gastric mucosa were associated with decreased hexosamine 
uptake.
Carbenoxolone which has been shown in a large number of c lin ica l 
tr ia ls  (Pinder et a^, 1976) to be efficacious in the treatment of 
gastric ulceration was shown to markedly increase mucus synthesis, 
measured by the incorporation of N-acetylglucosamine,to normal or greater 
levels during the course of successful therapy. This finding is in 
good agreement with that of Domschke et al_ (1972) who showed that 
N-acetylneuraminic acid levels which were depleted in the mucus of 
gastric ulcer patients were elevated by carbenoxolone treatment.
Contrary to the views of Lambert and Andre (1972) i t  was shown that 
the human gastric mucosa was capable of synthesizing sulphated glyco­
proteins. However, unlike the rat (Lambert et al_, 1969) and the pig 
(Rainsford, 1975) in which ulcerogenic stimuli resulted in decreased 
sulphation of glycoproteins, sulphate incorporation was elevated in 
human chronic gastric ulcer and carcinoma. This may represent a species 
difference between humans and other species with regard to sulphation 
of glycoproteins. In rats carbenoxolone pretreatment resulted in 
increased synthesis o f these compounds. I t  would be of in terest to 
study the effects of the drug on sulphate incorporation in humans to 
establish whether the proposed species difference would result in 
carbenoxolone causing a decrease.
The majority of animal experiments concerning the ulcerogenic and 
anti-ulcerogenic effects of drugs on glycoprotein synthesis were 
carried out in the ra t. Studies indicated that this species synthesised 
activated precursors and incorporated them into glycoproteins by established 
mechanisms. The water soluble mucosubstance consisted of low and high
c
molecular weight glycoproteins (approx. 1.2 x 10 and in excess of
c
1 x 10 respectively) which appear to be related biosynthetically. I t  
is possible that the higher molecular weight molecule may represent a 
repeating unit of the smaller glycoprotein. Similar results have been 
obtained by Allen and Snary (1972) for pig gastric mucin and by Lukie 
and Forstner (1972) for rat intestinal mucin. Thus the association of 
re la tive ly  low molecular weight subunits to produce large and complex 
glycoproteins may be general.
In general, factors which have been reported as causing mucosal 
damage led to a decrease in glycoprotein synthesis and those associated
with ulcer healing led to an increase when administered to rats. Thus 
the incorporation assay may represent a useful tool in screening new 
drugs for ulcerogenic or anti-ulcerogenic potential. However, the 
result with indomethacin and sim ilar results which have been obtained 
for phenylbutazone (Ioannides, 1976) indicate that the length of the 
dosing period is c r it ic a l since in the short term mucosal damaging 
agents have an apparent stimulating effect on glycoprotein synthesis, 
perhaps through an ir r ita n t  e ffect on undamaged mucosal c e lls .
A number of mechanisms have been proposed for stress and drug 
induced gastric lesions including mucosal ischaemia resulting in 
impaired energy metabolism, damage to the endoplasmic reticulum, lysis  
of lysosomes and inhibition of hexosamine synthesis. A ll o f these 
mechanisms w ill result (e ither as a primary effect e.g. d irect enzyme 
inh ib ition , Or a secondary e ffec t, e.g. impaired energy metabolism) 
in interference with the synthesis of nucleotide sugars.and a derangement 
of mucus synthesis which may aid the development of the observed lesion. 
In the case of ethanol and p en ic illin  i t  may be argued that a disturbance 
in mucus synthesis precedes the development of the lesion since decreased 
incorporation rates were detected in mucosae without erosions as well as 
those with erosions.
In contrast to these agents carbenoxolone caused an increase in 
hexosamine incorporation when administered to rats . Although the ra t 
is not the best experimental animal for use in studies on carbenoxolone 
since i t  has been shown to metabolise the drug somewhat d iffe re n tly  
to man (Iveson et al_, 1971), carbenoxolone was shown to e l ic i t  the 
same effects on mucus synthesis in the stomach of the fe rre t which has 
been shown by Shillingford (1975) to metabolise the drug in the same way 
as man.
The effect of carbenoxolone on mucus synthesis appears to be 
on the structure of the oligosaccharide chain rather than on the 
overall amount of mucus synthesised, giving rise to a glycoprotein 
apparently richer in N-acetylhexosamines and s ia lic  acid and 
depleted v/ith respect to galactose. Menguy and Desbaillets (1968) 
found that mucin from rats treated with indomethacin and phenyl­
butazone which caused reductions in the concentration of protein- 
bound carbohydrates, particu larly  s ia lic  acid and hexosamine, was 
digested more rapidly by pepsin than normal mucin. Thus by causing 
an increase in the concentration of hexosamines and s ia lic  acids 
carbenoxolone w ill give rise to a glycoprotein which is more resistant 
to proteolytic digestion and a more protective mucosal barrier. Such 
an effect might explain the early observations of Hausmann and Tarnoky 
(1966) who found apparent increases in the amount of v is ib le  mucus in 
the stomachs of patients treated with carbenoxolone since a more stable 
mucus w ill persist for longer periods on the surface of the mucosa.
Carbenoxolone may also exert its  beneficial action in the 
treatment of gastric ulceration through its  a b ility  to s tab ilize  
lysosomes. These organelles contain hydrolytic enzymes capable of 
degrading a ll ce llu la r macromolecules and have been shown to release 
th e ir contents under the influence of ulcerogenic stimuli such as 
stress (Fergusson et a]_, 1972) and non-steroidal anti-inflammatory 
drugs (Lewis et jH_, 1971). Among the macromolecules degradable by 
lyosomal hydrolases are the mucous glycoproteins (Chapter 4 ).
Whether lysosomal rupture is a primary causative agent or secondary 
to the development of the ulcer the release of the contained lysosomes 
would certainly aid the further development of the lesion.
The stabilisation of lysosomal membranes although possibly of
importance in the ulcer healing action of carbenoxolone may be merely 
an example of a general effect of the drug on biological membranes.
Such a general membrane action has been suggested by Symons (1976) and 
may explain other observed effects of carbenoxolone such as the 
decreased cell turnover noted by Lipkin (1971).
S im ilarly, the membrane a c tiv ity  of the drug may explain the 
observed effects on mucus synthesis. The build up of glycoproteins 
commences by the synthesis of the polypeptide chain in the ribosomes 
attached to the endoplasmic reticulum and proceeds by stepwise addition 
of carbohydrate units by specific glycosyl transferases which are also 
membrane bound. Thus i t  is conceivable that carbenoxolone may s im ilarly  
stab ilize  the rough endoplasmic reticulum of the mucosal cell thus 
resulting in the observed changes in glycoprotein synthesis.
I t  may also be argued that gastric ulceration may arise through a 
derangement of the endoplasmic reticulum leading to production of a 
mucous glycoprotein with altered oligosaccharide chains giving a less 
protective mucus and an impaired mucosal barrier, resulting in the 
c lin ic a lly  observed lesion. This alteration in glycoprotein synthesis 
may be sim ilar to the 'switchover' from the synthesis o f secreted to 
non-secreted proteins associated with dissociation of the ribosomes 
from the endoplasmic reticulum. This process, which is normally 
regulated by steroid hormones (Sunshine £ t  a^, 1971) may explain 
the low incidence of gastric ulceration observed during pregnancy. 
Dissociation of the ribosomes is also stimulated by starvation and 
this has been shown to adversely a ffect mucus synthesis.
A sim ilar degranulation i . e . ,  the conversion of rough to smooth 
endoplasmic reticulum is caused by carcinogens. In this case, however,
the change is thought to be irreversib le. A possible correlation  
between gastric carcinoma and ulceration has previously been mentioned 
and i t  has been shown that the effect on glycoprotein synthesis measured 
by the incorporation of hexosamine and sulphate due to the two lesions 
is sim ilar. Furthermore, i t  has recently been shown that pretreatment 
of rats with carbenoxolone at dose levels which e l ic i t  effects on 
glycoprotein synthesis prevented the activation of biphenyl-2-hydroxylase, 
an indicator of ribosome removal and endoplasmic re ticu lar damage, in 
the liv e r and stomach (Parke, 1976).
Schrager and Oates (1973) have shown that gastric carcinoma is  
associated with alterations in the structure of the glycoprotein oligo­
saccharides. I t  would be of interest to study hydrolysis fragments of 
glycoproteins from the mucus of gastric ulcer patients by the same 
technique of gas liquid chromatography to see i f  sim ilar modified glyco­
proteins are produced in this lesion and whether carbenoxolone has a 
'normalising1 effect on this structure. Furthermore, the e ffec t of 
carbenoxolone on the interactions of ribosomes with the endoplasmic 
reticulum with relation to ulcerogenesis and carcinogenesis warrants 
investigation.
The E type prostaglandins and th e ir analogues also caused an increase 
in incorporation of hexosamine indicating that they too may exert th e ir  
beneficial effects in the treatment o f gastric ulcer by an e ffec t on 
mucus synthesis. Moreover, the existence of endogenous E type prosta­
glandins in the stomach (Shaw and Ramwell, 1968) suggests that they may 
have a physiological role in the maintenance of the gastric mucosal 
barrier.
A correlation appears to exist between the actions of the prostaglandi
and carbenoxolone. Both have been shown to effect mucus synthesis
and stab ilise lysosomal membranes. The link between the two
compounds is further evidenced by the finding of Peskar et al
(1975) that carbenoxolone inhibited the enzymes responsible for
the degradation of the prostaglandins. Hence the possib ility
that carbenoxolone might exert some of its  beneficial action
through potentiation of endogenous prostaglandins merits investigation.
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